curriculum vitae, - inhninhn.org/fileadmin/archives_new/glick_cv.pdf · 1968 army commendation...
TRANSCRIPT
1
1
Archives
(Glick Collection)
September 10, 2015
Revised, June 21, 2015,
Curriculum Vitae,
Ira David Glick, MD
Professor Emeritus of Psychiatry, Dept. of Psychiatry & Behavioral Sciences
Stanford University School of Medicine;
401 Quarry Road
Stanford, CA 94305-5546
(650) 799 1583 (cell)
Visiting Scholar, School of Medicine, University of California, San Diego, La Jolla, Ca
Visiting Fellow in Psychiatry, Weill Cornell Medical College, New York, N Y
Date of Birth: October 15, 1935 Place of Birth: Brooklyn, New York
Education:
1957 B.S., Dickinson College, Carlisle, Pennsylvania
1961 M.D., New York Medical College, New York, New York
Postgraduate Education:
1961-1962 Rotating Internship, Beth Israel Hospital, New York, NY
1962-1966 Psychiatry Residency
1962-63 - First Year Resident, Hillside Hospital, Glen Oaks, New York
1963-64 - Second Year Resident, Mt. Zion Hospital, San Francisco, California
1964-65 - Chief Resident, Hillside Hospital
1965-1966 Candidate, New York Psychoanalytic Institute, New York, NY
Licensure & Certification:
1962-1993 New York State Medical License
1963 Diplomate of the National Board of Medical Examiners
1963- California State Medical License (G 9084)
1968 Diplomate of the American Board of Psychiatry and Neurology
1980 Mental Health Administrator, Commission on Certification in Administrative Psychiatry of
the American Psychiatric Association
1988-1990 Maryland Medical License
Academic Appointments:
2
2
1965-1968 Instructor & Assistant Attending Psychiatrist, New York State Psychiatric Institute,
College of Physicians and Surgeons, Columbia University
1966-1968 Assistant Clinical Professor of Psychiatry, Medical College of Georgia
1968-1978 School of Medicine, University of California, San Francisco (UCSF):
1968-72 Assistant Clinical Professor of Psychiatry and of Obstetrics & Gynecology
1971-73 Career Teacher in Psychiatry of the National Institute of Mental Health at
Langley Porter Neuropsychiatric Institute
1972-76 Associate Clinical Professor
1976-78 Professor of Psychiatry in Residence, School of Medicine
1978-1993 Professor of Psychiatry, Cornell University Medical College, New York, NY
1993- Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine
• 2010 Emeritus Professor
Positions:
1965-1966 Staff Psychiatrist and Research Associate, Hillside Hospital, Glen Oaks, New York
1966-1968 Service Record: Captain, Army of the United States, Chief, Psychiatry Service,
U.S. Army Hospital Specialized Treatment Center, Fort Gordon, Georgia
1968-1978 Langley Porter Neuropsychiatric Institute and Dept. of Psychiatry, School of Medicine,
University of California, San Francisco
1968-78 Chief, Clinical Research Ward (renamed the Inpatient Treatment & Research
Service, 5/1/75)
1975-78 Director, Medical Student Education
1978-1993 Associate Medical Director, Payne Whitney Clinic, Dept. of Psychiatry, The New York Hospital-
Cornell Medical Center
1978-88 - Director, Inpatient Services
1978-93 - Director of the Family Therapy Program
1990-93 - Director, Outpatient Dept.
1988-1990 Senior Science Advisor to the Director, National Institute of Mental Health, Rockville, MD, 80%
1993- Stanford University School of Medicine & Stanford University Hospital
1993 - 2000 - Director of Inpatient & Partial Hospitalization Services,
1995 - 96 - Acting Deputy Chief of Staff and Chief of Psychiatry,
Palo Alto Veterans Administration Hospital
1993 – 2012 - Director, Schizophrenia Research Clinic
2010- Medical Director, Pacific Research Partners, Oakland, CA
2000- The American Society of Clinical Psychopharmacology
Editor, Model Psychopharmacology Curriculums for Teachers of Psychopharmacology to
Residents, Medical Students and Primary Care Physicians,
Private Practice:
New York City: 1965-66 and 1978-93
San Francisco:
o 1968-78 and 1993-present
3
3
Other Training:
1965-1966 Dept. of Research, Hillside Hospital: Seminar on Research Methods in Psychiatry, D. Klein, MD
1968-1969 J. Starkweather, PhD, Dept. of Information Systems, UCSF: An Introduction to Computer
Programming PL-1
1968-1969 Dept. of Psychiatry, UCSF: Seminar on Supervision, R. Wallerstein, MD
1968-1969 Dept. of Psychiatry, UCSF: Seminars on Models in Psychiatry, J. Ruesch, MD
1969-1970 Dept. of Psychology, Langley Porter Neuropsychiatric Institute: Course on Advanced
Statistics, W. Hargreaves, PhD
1971-1972 Dept. of Psychology, Langley Porter Neuropsychiatric Institute: Advanced Statistics
226- A & B, R. Elashoff, PhD and W. Hargreaves, PhD
1971-1972 UCSF: Health Sciences Education Seminar, E. Rosinski, PhD
1972 Dept. of Anatomy, UCSF: Course on Cell Structure & Function, R. Long, PhD
1972 Dept. of Physiology, UCSF: Course, Endocrinology 101, C. Kragt, PhD
1972 Dept. of Business Administration, Philosophy of Management University of California,
Berkeley Science, C. Churchman, PhD
1973 Cardiovascular Research Institute, UCSF: Group Practice in the Art of Teaching, N. Staub, MD
1978-1979 Dept. of Psychiatry, Albert Einstein College of Medicine: Administrative Psychiatry &
Mental Health Planning, S. R. Kaplan, MD
Honors and Awards:
1953-1954 Skull & Key Award: Dickinson College. One award, given yearly to the college's “most outstanding
freshman”
1959 National Foundation Medical Student Fellowship, Dept. of Physical Medicine & Rehabilitation,
New York Medical College (Summer)
1960 National Institute of Mental Health Research Training Grant , Dept. of Psychiatry, New York
Medical College (Summer)
1961 Stephen P. Jewett Award : Dept. of Psychiatry, New York Medical College. One award given
each year for proficiency in psychiatry to a fourth year medical student
1968 Army Commendation Medal : U.S. Army Hospital, Ft. Gordon, Georgia
1971-1973 Career Teacher in Psychiatry: National Institute of Mental Health, MH-12450
1974-1975 Dept. of Psychiatry Nominee for the Kaiser Award for Excellence in Teaching, and
the UCSF Budget Committee Award for Special Recognition of Distinction in Teaching
1979 American Journal of Nursing, 1979, Books of the Year Award, presented for "Psychiatric
Hospital Treatment for the 1980's"
4
4
1974-1978 Consultant, Psychiatric Education Branch of the National Institute of Mental Health
1979-1980 Ad Hoc Reviewer for the Psychosocial & Biobehavioral Treatments Subcommittee of the
Treatment Development and Assessment Research Review Committee, NIMH
1982 Member, Special Review Committee on Depression, ADAMHA, NIMH (July)
1987 Fulbright Research Scholar, Japan, (January through July)
1987 Research Fellowship, the Japanese National Institute of Mental Health, Itchikawa, Japan,
(January through July)
1987 The American Psychiatric Association and Psychiatric Institute of America (PIA) Award for
Hospital Psychiatric Research, awarded annually for research in the field of hospital psychiatric
treatment.
1986- The Best Doctors in America
1990 The Seymour D. Vestermark Award, awarded annually "to recognize leadership & creativity in
psychiatric education, "by the American Psychiatric Association, (given to the ACNP for a Model
Curriculum in Psychopharmacology developed by a subcommittee which I co-chaired with David
Janowsky, MD)
1990 Director's Award, National Institute of Mental Health
1991 The Association for Academic Psychiatry Psychiatric Education Award, Honorable Mention,
awarded biannually for Innovative Educational Materials and Techniques, for the Model
Curriculum in Psychopharmacology
1991 One of three recipients of Alumni Achievement Awards from New York Medical College
1991 Runner-up for The American Academy of Clinical Psychiatrists Clinical Research Award
1991-1994 MacArthur Foundation Research Network on Depression
1993 The Van Ameringen Award in Psychiatric Rehabilitation, awarded annually by American Psychiatric
Association, in recognition of outstanding and sustained contributions to field of psychiatric
rehabilitation in areas of research, service and education (in 1992, I was given “Honorable Mention”
for this same award)
1994 The Alexander Gralnick Award,for Research in Schizophrenia, given annually by the American
Psychiatric Foundation to a researcher “whose work covers the psychosocial aspects of
schizophrenia with an emphasis on the early stages of the disorder.”
1996 Association for Academic Psychiatry Annual 1997 Education Award for “outstanding
contributions as an educator, both in curriculum development and in presentation”
2000 Annual Outstanding Achievement Award of the Northern California Psychiatric Society (NCPS) of
the APA, “recognizes a member of NCPS who has made significant and exceptional contributions
to the field of psychiatry.”
2001 Distinguished Contribution to Family Systems Research Award. This annual AFTA award
recognizes an individual for outstanding research on subjects central to the field of family therapy.
5
5
2002 Rockefeller Foundation Award for Residence at Bellagio, Italy, Summer 2002.
2003 Metzger-Conway Fellow, Clarke Center, Dickinson College, Carlisle, PA
2003 Fulbright Lecturing Award, India
2004 Excellence in Teaching Award, Stanford University School of Medicine, Stanford, CA. In
recognition of “contributions to the educational mission of the school.”
2004 Nominee for Franklin G. Ebaugh, Jr. Award for excellence in teaching, Stanford University School
of Medicine
2005 First Annual Irma Bland Award for Excellence in Teaching Residents, given annually by the
American Psychiatric Association to Departments of Psychiatry for” outstanding and sustaining
contributions made as a faculty.”
2005 Paul Hoch Distinguished Service Award for Contributions to the College, from the American
College of Neuropsychopharmacology
2006 Dickinson College Distinguished Alumni Award for Professional Achievement. This yearly award
names alumni “ who have demonstrated outstanding accomplishment, as well as strength of
character, in their professional and civic lives.”
2006 CINP 2006 Lundbeck Neuroscience Foundation Prize for Education in Psychiatry and Neurology,
one award given every 2 years for “education in psychiatry and neuroscience to an individual (or
group) who has attained particularly valuable achievements in the field of postgraduate education
in psychiatry and neuroscience.”
2008 The American College of Psychiatrists’ (ACP) Distinguished Service in Psychiatry Award, one
award given each year to “recognize distinguished achievements and leadership in the field of
psychiatry. “
2008 The Association for Academic Psychiatry, Distinguished Life Fellow, given each year for “mastery
in a career dedicated to educational endeavors, demonstrated generativity by unselfishly guiding
the next generation of academic psychiatrists, and engaged in passing on the traditions of the
past to the next generation of academic psychiatrists. “
2010 Exemplatory Psychiatrist Award, from the National Alliance of Mental Illness (NAMI), the largest
family mental health advocacy group in the country, for ” his work in helping patients and families
with serious mental illnesses.”
2013 2014 American Psychiatric Association Kun-Po Soo Award, “recognizing an individual who has
made significant contributions toward understanding the impact and import of Asian cultural
heritage in areas relevant to psychiatry,”
Visiting Professorships (VP) & Endowed Lectures:
1972 VP: Dept. of Psychiatry, School of Medicine, University of San Marcos, Lima, Peru, (August)
1) Teaching of Psychiatry to Medical Students
2) Family Therapy Today
1978-1988 Distinguished Lecturer, Lederle Pharmaceutical Co
6
6
1979 VP: Dept. of Psychiatry, College of Medicine, University of Arizona, Health Science Center,
Tucson, Arizona
1980 Gary N. Spero Community Mental Health Memorial Lecture Series, "The Family Model in
Inpatient and Day Hospital Settings," Maimonides Medical Center, Brooklyn
1980 VP: Dept. of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut
1981 VP: Maudsley Hospital, Tavistock Clinic and Hospital for Sick Children, London
1) "The Family Model in an Inpatient Setting", Seminar on Hospital Psychiatry,
Mental Health Workers, Great Britain
2) "Family Therapy and Hospitalization", Tavistock Clinic
3) "Family Research", Marlborough Hospital
4) "Family Research", Grand Rounds, Hospital for Sick Children
5) "Indications and Contraindications for Family Therapy", The Family Institute of London
1982 Keynote Address, "Guidelines for Family Therapy," as part of a continuing education course
entitled "Clinical Techniques for the Practice of Family Therapy," sponsored by the Dept. of
Psychiatry, Long Island Jewish- Hillside Medical Center
1982-1989 Visiting Faculty Program, Mead Johnson Pharmaceutical Co.
1983 VP: Dept. of Psychiatry, University of California, San Diego
1983 VP: Dept. of Psychiatry, College of Medicine, University of Arizona Health Sciences Center,
Tucson
1984 Schweppes Visiting Professor, The Menninger Clinic, Topeka
1985 VP: Dept. of Psychiatry, University of Wisconsin Medical School, Madison, "The Shrinking of
Hospital Psychiatry"
1985 VP, Dept. of Psychiatry, Medical University of South Carolina, Charleston
1) Grand Rounds, "Inpatient Family Intervention - A Controlled Study"
2) Inge Taylor Memorial Lecture, "Why Don't Patients Receive Appropriate Psychiatric
Treatment?"
3) All Day Seminar with Psychiatry Residents, "Theory & Practice of Integrative Psychiatry"
1985 VP: Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine,
Dept. of Psychiatry, "The Family Model: Does It Have Anything to Offer for the Treatment of
Affective Disorders?"
1985 VP: Fairfield Hills Hospital, Newtown, Connecticut, "Treating the Hospitalized Patient and
Their Family"
1986 VP: Dept. of Psychiatry, School of Medicine, University of Verona, Italy, Jan-Jun
1990 Visiting Lecturer Series, "Effectiveness in Psychiatric Care," New Jersey College of Medicine
and Dentistry, Newark
1990 Invited Speaker, "What a Psychiatric Hospital Can and Cannot Do: A Review of Efficacy
Studies." at a conference, "The Role of the Mental Hospital in the 21st Century," sponsored
by the London Psychiatric Hospital, Ontario, Canada
7
7
1990 Invited Lecture, "New Wine in New Bottles: The Changing Role of Psychiatric Hospitals for
Patients and Their Families," at The Sheppard Pratt National Symposium on Schizophrenia,
Baltimore
1991 Academic Lecture: "New Models for the Treatment of the Chronically Mentally Ill," Annual
Meeting of the Ontario Psychiatric Association, Toronto (February)
1991 Invited Lecture: "A Survival Guide for the Family of the Borderline Patient (and Vice Versa),"
New Approaches to the "Borderline Syndrome," Sixth Tokyo Institute of Psychiatry
International Symposium, Tokyo, Japan (November)
1993 VP & Invited Lecture: University Institutions of Psychiatry, Geneva, School of Medicine,
University of Geneva, Switzerland and Invited Lecture, "Effectiveness in Psychiatric Care: A
Followup Study of the Treatment of Hospitalized Patients with Major Affective Disorder seen
in Europe, Asia and the U.S. United States" (April)
1993 VP: Institute of Clinical Psychiatry, School of Medicine, University of Pisa, Pisa, Italy, with
Invited Lecture, "Effectiveness in Psychiatric Care: A Followup Study of the Treatment of
Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States"
1993 Invited Lecture, "Effectiveness in Psychiatric Care: A Followup Study of the Treatment of
Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States,"
Dept. of Psychiatry, Second School of Medicine, Naples, Italy (April)
1993 Invited Lecture, "Effectiveness in Psychiatric Care: A Followup Study of the Treatment of
Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States,"
Institute of Clinical Psychiatry and the Dept. of Psychiatry, School of Medicine, Verona, Italy.
1994 Academic Lecture: "Combining Medications with Psychosocial and Rehabilitation Strategies
for the 1990's," 2nd Annual Psychopharmacology Clinical Day, Department of Psychiatry,
University of Toronto, Toronto (October).
1995 Distinguished Lecturer, Professors of Psychiatry Series: New Strategies of Treatment for Axis I
Disorders, 1995.
1995 VP, Department of Psychiatry, School of Medicine and Surgery, University of Bari, Italy, June.
Keynote Speaker, Strategies of Intervention in Family Psychotherapy, First National
Congress, Italian Society for Research and Interventions on the Family, Subsection of the
Italian Psychiatric Society .
1996 Keynote Address, Combination Therapy for the Treatment of Psychosis, Third Annual STEP
Symposium, Improving the Prognosis of Psychotic Disorders (Schizophrenia Treatment &
Evaluation Program), University of North Carolina at Chapel Hill, June, 1996.
1996 Keynote Address, Combination Therapy for the Treatment of Axis I Disorders, 1996 Taipei
Mental Health Conference, Taipei, Taiwan, December 1996.
1997 VP, Department of Psychiatry, University of Iowa Hospital and Clinics, Iowa City, March 1997.
1997 Award Lecture, Through the Golden Chalkboard: Reflections on the Teaching-Learning Process
in Psychiatry, 1997 Annual Meeting of the Association of Academic Psychiatry, March, 1997.
1998 VP, Department of Psychiatry & Internal Medicine, St. Francis Medical Center, Pittsburgh, PA,
1998.
8
8
1998 Principal Speaker, “Lone Star : Society, The Family and Individual Identity,” as part of the film
series of the New Orleans Museum of Art and Department of Psychiatry LSU, entitled: Lights,
Camera - Analysis, “ New Orleans, October, 1998.
1998 Keynote Speaker, “New Treatments for Schizophrenia and Other Psychoses,” at the National
Satellite Symposium for the Argentine Psychiatric Society, “Time for Change in the Treatment of
Psychosis, “ Buenos Aires, Argentina, November, 1998.
1998 Principal Speaker, at the National Conference organized by the Uruguayan Ministry of Health,
Uruguayan Society of Psychiatry and the Psychiatric Department of the School of Medicine in
the National University, Montevideo, Uruguay, November 1998:
• “New Atypical Antipsychotics and Their Indications”
• “Combining Medication and Psychotherapy for Axis I Disorders”
1999 Visiting Professor, University Hospital Utrecht, The Netherlands, Summer 1999.
1999 Plenary lectures at the Schizophrenia Symposium, Eastern Idaho Regional Medical Center, Idaho
Falls, ID, June, 1999:
• “New Strategies for the Treatment of Axis I Disorders”
• “New Treatments for Schizophrenia”
1999 Plenary Lecture, “New Diagnostic Methods and Treatments for Schizophrenia: Turning the
Treatment Corner” at the Annual Meeting of the Canadian Psychopharmacologic Association,
Halifax, June, 1999
2000 Guest Lecture, “The New Atypical Antipsychotics for New Indications,” Annual Meeting, Korean
Psychopharmacology Association, Korea, April, 2000.
2000 Visiting Professor, EPPIC Program, University of Melbourne, Melbourne, Australia, August, 2000.
2002 Invited Lecture, “Novel Antipsychotics: What We’ve Learned; What We Need to Know.” CME
course on Novel Antipsychotics, Case Western Reserve University School of Medicine,
Cleveland, September, 2002.
2004 Visiting Professor, Family Studies Unit, National Institute Mental Health and Health Series
(NIMHANS), Bangalore, India
• “Combining Medication and Psychotherapy”
• “The New Model of Inpatient Psychiatry”
2004 Inaugural Lecture, “Gary N. Spero Memorial Lectureship, “Schizophrenia and Psychosis: New
Data, New (Combined) Treatments & New Controversies.” Department of Psychiatry, Weill
Medical College of Cornell University, New York, March, 2004.
2004 Visiting Professor, School of Medicine, University of Iowa
• Combining Medication and Psychotherapy for Axis I Disorders
• Schizophrenia: New Data and New Controversies
2005 At the Indonesian Society for Biological Psychiatry, Psychopharmacology and Sleep Medicine,
Jakarta, Indonesia, February, 2005.
• Educational Symposia, “The Teaching of Psychopharmacology: Circa 2005”
• Opening Plenary Lecture: “Developing a Curriculum in Psychopharmacology”
9
9
2005 Lecture: “Developing a Curriculum in Psychopharmacology.” Teaching Psychopharmacology:
Substance, Methods, Science. Pre-Meeting: American Association of Directors of Psychiatric
Residency Training, Tucson, AZ, March, 2005
2005 Invited Lecture, “Collaboration With Big Pharma,” as part of the Stanford Summer Research
Institute, entitled Careers in Geriatric Psychopharmacology. Stanford, CA, July, 2005
2006 Invited Lecture. “Using a Psychopharmacology Curriculum to Improve Training.” Dept of
Psychiatry, Cape Town Medical School, Cape Town, South Africa, April, 2006
2006 Invited Lecture: “CATIE Trial Results.” At the Annual ECNP (European College of
Neuropsychopharmacology) Meeting, Paris, September 2006.
2007 Invited Lecture: “Clinical Antipsychotic Trials in Intervention Effectiveness.” Oregon Psychiatric
Association, Lake Oswego-Portland, OR, March 2007.
• Panel Discussion on CATIE trial, “ with W Hoffman, M Reaves, D Ruthven
2007 Invited Lecture: “Teaching of Psychopharmacology Worldwide,” consultant for the Lundbeck
Institute, Copenhagen, Denmark, March 2007.
2007 Invited Participant: “Joint Committee on Long-Term Management of Schizophrenia,” Houston,
April and October, 2007, Chaired by William Carpenter and John Newcomer.
2008 Visiting Professor and Invited Lectures: “The Teaching of Psychopharmacology: 2008,”
• Department of Psychiatry, Sackler School of Medicine, Tel Aviv University
and Sheba Medical Center, Tel Aviv, Israel
• Department of Psychiatry, Rappoport Faculty of Medicine Institute of Technology, Technion,
Haifa, Israel
2008-2011 Visiting Professor and Invited Lectures at the Institute of Clinical Psychiatry and Polyclinica
Hospital, University of Milan, Italy.
• 1) “Update on Treatment of Schizophrenia”
• 2) “Combining Medication with Psychotherapy for Axis I Disorders.”
2009 Invited Lecturer: “How We Should Teach Psychopharmacology,” ECNP School of
Neuropsychopharmacology, St Catherine’s College, Oxford, England, July, 2009
2009 Inviited Lecture: “Current Status and Overview of Marital and Family Psychotherapy, at the
Psychotherapy Institute, Dept of Psychiatry, School of Medicine, University of Verona, Italy,
October, 2009
2010 Visiting Professor and Invited Lecture at the Department of Psychiatry, Penn State College of
Medicine, Hershey, PA, January 2010
• “Long-term Treatment of Schizophrenia with Antipsychotics: Recent Research”
• “Combining Drugs and Psychotherapy for Axis I Disorders”
2010 Visiting Professor, sponsored by the Clark Center at Dickinson College, Carlisle, PA, Jan 2010
• “The New Neuroscience, Psychology and Psychiatry: History and Challenges for the Future
• “The Athlete as Role Model: Life after Sports”
2010 Visiting Professor, Update on the Treatment of Schizophrenia, School of Medicine, University
Psychiatric Center, Casablanca Morocco, April, 2010
2011 Visiting Professor and Invited Lecturer: 1) Combining Medications and Psychotherapy for
10
10
Axis I Disorders, and 2) Updates on Treatment of Schizophrenia, at the Department of
Psychiatry, School of Medicine, Penn State Hershey, November 2011.
2011 Plenary Lecture, Psychopharmacologic Treatments for Schizophrenia, at the Annual Meeting of
the Nevada Psychiatric Association, Las Vegas, February 2011
2012 Course Coordinator and Lecture, Update on Schizophrenia, at the Annual CME Course for the
Nevada Psychiatric Society, Las Vegas, February, 2012
Lecture, Long-term Management and Treatment of Chronic Schizophrenia
2013 Invited Plenary Lecture: Pulling Together the Data: Lifetime Treatment of Schizophrenia, Annual
Meeting, Alberta Psychiatric Society, Banff, Canada, March, 2013.
2013 Invited Grand Rounds: Mid-term and Long-term Treatment of Schizophrenia, Harvard Longwood-
Mass Mental Psychiatry Department, Boston, March, 2013.
2014 Invited Lecture: The New Neuroscience-and Psychology, Psychiatry and Medicine, The Clarke
Forum for Contemporary Issues, Dickinson College, Carlisle, Pa, Feb. 2014 and at Dept of
Neuroscience, Wesleyan University, Middletown, Conn, May, 2014.
2014 Award Lecture: The Ascent of Asian Psychiatry, delivered for the Kim-Po Soo Award at the Annual
Meeting of the American Psychiatric Association, New York, May, 2014.
2014 Visiting Scholar Series: Mid and Long-Term Treatment of Schizophrenia McLean Hospital,
Harvard Medical School, Boston, September, 2014.
2015 Distinguished Speaker Series: Combining Psychotherapy with Pharmacotherapy: Data, Benefits
and Guidelines for Integration, Semel Institute for Neuroscience and Human Behavior at UCLA,
Los Angeles, March, 2015
Funded Research Activities:
1965-66 G.D. Searle Research Grant for the study
Pseudopregnancy Treatment of Periodic Psychiatric Illness
1971-75 National Institute of Mental Health Grant for the project MH-20593
Short vs. Long Psychiatric Hospitalization: A Controlled Study $133,000
Supplement $ 25,484
1975-77 Lederle Research Grant for the study
Loxitane Treatment in Schizophrenia
1977-1978 Endo Research Grant for the study
Molidone Hydrochloride vs. Haloperiodol:
Double Blind Investigation of the Treatment of Acute Schizophrenia
1977-1982 National Institute of Mental Health Grant for
Medical Student Psychiatric Education, MH-10569 $395,280
1977-1978 Vice Chancellor's Advisory Committee on Instructional
11
11
Improvements Grant, UCSF, for project Effectiveness and
Efficiency in Small Group Teaching with Mary Malloy, MD $ 1,400
1982-1983 National Institute of Mental Health - Biomedical Research Support
Grant for the study Inpatient Family Intervention: A Controlled Study $ 15,000
1982-1983 National Institute of Mental Health Contract -to develop a Model
Psychopharmacology Curriculum for Psychiatric Residency Training
Programs 83K055987501D (with David Janowsky MD) under the
auspices of the American College of Neuropsychopharmacology $ 4,290
1984-1986 National Institute of Mental Health Grant for project
Inpatient Family Intervention: Evaluation of Practice, MH-34466 $180,000
1984-1993 National Institute of Mental Health, Cooperative Clinical Agreement Award
for the project, Treatment Strategies in Schizophrenia, MH-40007 $863,000
1987-89 Supplement $104,000
1989-92 Competitive Renewal $688,581
1992-93 Supplement $ 30,000
1987 Fulbright Research Award for the project,
Delivery and Compliance to Good Medical Treatment $ 20,000
1991 Janssen Research Grant for the study, Risperidone in the
Treatment of the Negative Symptoms of Schizophrenia
1992-1995 National Institute of Mental Health Grant, Marital Treatment
for Bipolar Disorder Patients, MH-45528-01A3,
Co-Principal Investigator with John Clarkin, PhD, P.I. $520,000
1992 (Cornell) Abbott Laboratories Research Grant for the study: Depakote in the
& Prevention of Mania
1993 (Stanford)
1992 Pfizer Research Grant for the study: CP-88 for the Treatment
of Schizophrenia and Schizoaffective Disorder
1992 (Cornell) Abbott Laboratories Research Grant for the study: The Safety
& and Efficacy of Sertindole in Schizophrenic Patients:
1993 (Stanford) A Double-Blind, Haldol-Referenced, Placebo-Controlled Study
1993 Pharmacologic Medication Discovery & Development Project (PMDDP) $10,000
Supported by SmithKline Beecham, Lilly & Abbott Laboratories
1993 Pfizer Research Grant for the study, Treatment of Adolescent Depression
with Sertraline
1993 Abbott Laboratories Research Grant for the study, Safety and Efficacy
of Depakote in the Prevention of Mania in Patients With Bipolar Disorder
1995 Eli Lilly unrestricted treatment grant to develop a Model Psychopharmacology
Curriculum for Residents (Committee Chair) under the auspices of
the American Society of Clinical Psychopharmacology
12
12
1995 Eli Lily Research Grant for the study, Olanzapine versus Risperidone
in the Treatment of Schizophrenia and other Psychotic Disorders
1995 Upjohn Research Grant for the study, Dose-response Study in the $50,000
Treatment of Negative Symptoms of Schizophrenia with Pramipexole
1995 Abbott Laboratories Research Grant for the study, A Comparative Cost
Effectiveness Study of Depakote and Usual Care versus Lithium and
Usual Care in the Treatment of Bipolar Disorder
1996 Zeneca Pharmaceuticals Research Grant for the study, A Multicenter,
Open, Randomized Comparison of Seroquel and Usual Care on Health
Outcomes in Subjects with Schizophrenia and Schizoaffective Disorder
1997 Hoechst Marion Roussel Research Grant for the study, A Multicenter,
Randomized, Double-Blind, Placebo and Active Controlled Study of
MDL 100,907 in Schizophrenic and Schizoaffective Patients
1997 Otsuka America Pharmaceutical, Inc. Research Grant for the study,
A Phase III Double-Blind Placebo-Controlled Study of Aripiprazole
in the Treatment of Psychosis, with Risperidone as Active Control
1998 Novartis Pharmaceuticals Corporation, A Prospective, Randomized, International,
Parallel-group Comparison of Clozaril/Leponex vs. Zyprexa in the Reduction of
Suicidality in Patients with Schizophrenia or Schizoaffective Disorder Who Are At
Risk for Suicide
1998 Zeneca Pharmaceuticals Research Grant for the investigator initiated $100,000
study, Quetiapine vs Haloperidol Decanoate for the Long-Term
Treatment of Schizophrenia and Schizoaffective Disorder
with Marder S.
1998 Lilly Research Labs, The Acute and Long-Term Efficacy of Olanzapine
in First-Episode Psychotic Disorders: A Randomized Double-Blind
Comparison w/Haloperidol
1998 Pfizer Pharmaceuticals, A Multi-Center, Placebo Controlled Double Blind
Study Comparing the Safety and Efficacy of Ziprasidone and Olanzapine in
Subjects with Schizophrenia or Schizoaffective Disorder Needing Inpatient Care.
1999 Janssen Pharmaceutica, Risperidone Depot vs. Placebo in the Treatment of
Subjects with Schizophrenia or Schizoaffective Disorder
1999 Development of a Model Psychopharmacology Curriculum for Psychiatric
Residents. (through the American Society of Clinical Psychopharmacology) $15,000
Supported in part by Lilly, Janssen and Zeneca Pharmaceuticals.
2000 National Institute of Mental Health, sub-contract (MH90001), Comparative $550,000
Effectiveness of Antipsychotic Medications in Patients with Schizophrenia
CATIE.
• Human Genetics Initiative
2001 Bristol-Myers Squibb, A Multicenter, Randomized, Double-Blind, Placebo
Controlled Study of Flexible Doses of Aripiprazole Versus Perphenazine
13
13
In the Treatment of Patients with Treatment-Resistant Schizophrenia.
2003 Otsuka, An Open-Label Follow-Up Study of the Long-Term Safety of
Aripiprazole in Patients with Psychosis.
2003 Pfizer, Zodiac International Schizophrenia Study to Compare the Cardiovascular
Safety of Ziprasidone and Olanzapine.
2003 Pfizer, A 12 Week Multicenter, Randomized, Double-Blind, Placebo Controlled
Evaluation of Donepezil Hydrochloride as Adjunctive Therapy in the Treatment
of Cognitive Impairment in Patient with Schizophrenia or Schizoeffective Disorder
2004 Oshima Education Fund $30,000
2004 Astra-Zeneca, Comparison of Atypicals for First Episode (CAFE)
2004 Bristol-Myers Squibb, The Treatment of Schizophrenia and OCD $80,000
Symptomatology with Aripirazole (investigator initiated study).
2004 Bristol-Myers Squibb, Efficacy and Weight Reduction Effects of
Aripiprazole in Stabilized Patients with Schizophrenia and Weight Associated $105,000
with Atypical Antipsychotics (investigator initiated study w/Reaven).
2005 American College of Neuropsychopharmacology, ACNP Public Outreach $ 5,000
Program
2005 GlaxoSmithKline, Lamictal vs Depakote Double Blind. (investigator initiated $120,000
study)
2005 Solvay Pharmaceuticals, Parallel-Group Efficacy and Safety Study
of Two Fixed Doses of Bifeprunox in the Treatment of Schizophrenia.
2005 Co-Investigator of a Harman Clinic Endowment Grant for a project
Fostering Collaboration Through Clinical Education: A Clinical
Neurosciences Seminar, Clinic and Curriculum Series in Child
Psychiatry and Pediatric Neurology (with Joshi SV, Chang KD and
Hahn J).
2006 Shire, An Open-Label Study of Equetro in Outpatients With Aggressive $125,000
Symptoms & Behavior (investigator initiated study)
2006 Bristol-Myers Squibb, A Multicenter, Randomized, Double-blind,
Placebo-controlled, 16-week Study of Aripiprazole Used as Dual Therapy
in the Treatment of Patients with Chronic Stable Schizophrenia or
Schizoaffective Disorder Demonstrating an Inadequate Response to
Quetiapine or Risperidone Monotherapy.
2006 Pfizer, A Multicenter, Double-Blind, Flexible-Dose, 6-month Trial Comparing
the Efficacy and Safey of Asenapine w/Olanzapine in Stable Subjects w/
Predominant, Persistent Negative Symptoms of Schizophrenia.
2006 CAMP (Foundation for NIH), Clinical Management of Metabolic $116,900
Problems in Patients w/Schizophrenia: Switching to Aripiprazole v. Continued
Treatment w/Olanzapine, Quetiapine, or Risperidone
14
14
2007 American College of Neuropsychopharmacology, ACNP Public Outreach $5,000
Initiative. 2007 Schizophrenia Education Day. (also supported by Lilly, Janssen,
Astra-Zeneca)
2007 Lundbeck, A Randomized, Double-Blind, Parallel-Group, Flexible-Dose Study
Exploring The Neurocognitive Effect Of Sertindole Versus Quetiapine In Patients
With Schizophrenia Using The MATRICS Consensus Cognitive Battery (MCCB).
2007 Pfizer, A Six Week, Double-Blind, Placebo-Controlled Phase III Trial Evaluating the
Efficacy, Safety, and Pharmacokinetics of Flexible Doses of Oral Ziprasidone in
Adolescents with Schizophrenia.
2008 Eli Lilly, United BioSource Corporation, Validation of the Reasons for Antipsychotic
Discontinuation/Continuation Questionnaire (RAD-Q) and Interview (RAD-I)
2008 Keeping Up With Advances in Psychopharmacology in the New Millenium, $4,000
four lectures at medical schools in Israel, supported by the Sarlo Fund and the
Ingrid D. Tauber Philanthropic Fund from the Jewish Community Endowment
Fund, San Francisco, June, 2008.
2008 Schizophrenia Trials Network associated with NIMH Contract (N01MH90001)
• Comparison of Optimal Antipsychotic Treatment for Schizophrenia (COATS: A Pilot Study)
• Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia
(METS: A Pilot Study)
2008 Otsuka, A multicenter, Double-blind, Randomized, Active-controlled, Study to
Evaluate the Long-term Efficacy, Safety and Tolerability of an Intramuscular
Depot Formulation of Aripiprazole (OPC-14979) in Patients with Schizophrenia
(EU ASPIRE)
2009 ACNP, Educational Outreach Initiative Grant $5,000
2010- Multiple clinical trials of new medications for the treatment of mood disorders and schizophrenia,
at Pacific Research Partners, Oakland, CA. (list available on request)
Regional and National Professional Societies:
1965-1970 American Medical Association
1965- American Psychiatric Association
1971 Fellow
1985-92 Foundations' Fund Board for Research in Psychiatry
(Chair, 1985-92)
1999 Life Fellow
1999 Member, Committee on Research on Psychiatric Treatments,
Sub-committee on Antipsychotic Drugs & Diabetes Mellitus
2003 Northern California Psychiatric Society (NCPS)
• 2004-08 Committee on Awards
• 2009-12 Counselor-at-Large
++++++++++++++++++++++++++1970-1974 & American College of Psychiatrists
1990- 1990 Fellow
1996 -98 Committee on Honorary Fellowships
15
15
1970- Society of Biological Psychiatry
1991-93 Resource Development Committee
1997 Task Force on the Future of SBP
2001 George N. Thompson Award Committee, Society of Biological Psychiatry
1973- American College of Neuropsychopharmacology
1973 Scientific Associate
1978 Member
1980-84 Education and Training Committee, (Chair, 1982-84)
1984 Fellow
1984-90 Co-Chair, Committee to Develop a Model Curriculum in Psychopharmacology
1987-89 Committee on Problems of Public Concern
1989-91 Task Force on Coordinating Academic – Industry & Government Efforts
in Psychopharmacology
1989 & '96-98 Task Force on Psychotropic Drug Prescribing Privileges for Non-physicians
1988-92 Task Force on Scientific Misconduct
1994- Mentor, NIMH/Mead Johnson Minority Award Program
1995-97 Finance Committee (Chair, 1997-98)
2000-03 C+onstitution and Rules Committee (Chair, 2002-2004)
2005-09 Education and Training Committee
Co-Chair, 2005-7
2009-10 History Committee
2010-13 Public Information Committee
1973 Association for Academic Psychiatry, Charter Member
1978-80 Secretary
1983 Co-Chairman and Founder, Section on Residency Training
1983-84 Fellowship Committee
2008 Distinguished Life Fellow
1978 The Hastings Center-Institute of Society, Ethics and the Life Sciences
1978 American Family Therapy Academy
1982-84 Board of Trustees
1985 Committee on History of AFTA
1980 American Association of Psychiatric Administrators
1982 Association for Clinical Psychosocial Research, Founding Member
1982-85 Steering Committee
1988 Fellow
1984-94 Group for the Advancement of Psychiatry, Committee on the Family
1991 Program Committee
1992 Ad hoc Committee to Develop Practice Guidelines
1989 Psychiatric Research Society
1990 Collegium Internationale Neuro-Psychopharmacologicum (C.I.N.P.)
2002 CINP Regional Committee for North America
1992- Academia, Medicine & Psychiatric Foundation
1992 Fellow
1993- American Society of Clinical Psychopharmacology (A.S.C.P.), Founding Member
16
16
1993 - Model Curriculum Committee, Chair
1995 Work Group, Interface with Government & Industry, Clinical Trials Committee
1998 - Scientific Advisory Board
2001-2013 Treasurer
2005 Co-chair, Joint ASCP-AADPRT Curriculum Project
(with David Goldberg, MD)
2012 Finance Committee
1993- International Society for Sports Psychiatry, Founding Member
1993 - Chair, Scientific Program
1993 - Executive Board
2004 - 5 Chair, Nomination Committee
1997 West Coast College of Biological Psychiatry, Fellow
1998 Program Chair
1998 Pacific Rim College of Psychiatrists, Fellow
2011 World Affairs Council
Trustee, 2011-12
Education Committee, 2011-
2014 Collegium Internationale Neuropsychopharmacologie (CINP)
Education Committee, 2014-
Editorial and Advisory Boards:
1970-1981 Family Process
1981 Journal of Clinical Psychopharmacology
1981 Contemporary Family Therapy - An International Journal
1982- 2014 The Journal of Family Therapy (England)
1982-1995 Board of Advisors, Dickinson College
1984-1997 The Journal of Family Psychotherapy
1984-1987 National Council of Advisors on Development and External Affairs, UCSF
1989 Progress in Neuropsychology and Biological Psychiatry
1990-2 Advisory Board, MultiMedia Reviews in Psychiatry , Massachusetts General Hospital.
1993 Board Member, The National Mental Health Project
1993 Sertindole Advisory Board, , Neuroscience Venture, Abbott Laboratories
1995-1997 Gralnick Foundation Awards Committee
17
17
1996 CNS Science Advisory Board, Wyeth Ayerst Pharmaceutical
1997-9 Advisory Board, Janssen Pharmaceutica and Research Foundation
1997-9 Advisory Board, Institute for Healthcare Quality, Minneapolis
1997 Advisory Board, Zeneca Pharmaceuticals
1998 Advisory Board, Otsuka Pharmaceuticals
1999 Advisory Board, Hoechst Marion Roussel (Aventis)
1999 Advisory Board, NPSP Pharmaceuticals Bipolar Clinical Advisory Board, Boca Raton
2001, 5 Advisory Board, Pfizer (Geodon) Pharmaceuticals
2001 Board of Directors, National Foundation for Depressive Illness, Inc.
2002, 4, 5 Advisory Board, Shire Pharmaceuticals
2002, 3, 4, 5 Advisory Board, Bristol-Myers Squibb, California Neuroscience Advisory Board
2005- Editorial Board, The Journal of Clinical Psychiatry
2008- Editorial Board, The Physician and Sports Medicine
2009 Advisory Board, Pfizer. Anxiety Disorders
2011 Editorial Board, Revista Brasileira de Psiquiatria
2009 Scientific Advisory Board, Schizophrenia, Bristol-Myers Squibb
2012-2015 Member Data Monitoring Committee, VA Augmentation and Switching Treatment for Improving
Depression Outcome
2013 Scientific Advisory Board, Schizophrenia, Janssen Pharmaceuticals
2014 Editorial Board, CNS Spectrums
2014 Scientific Advisory Board, Schizophrenia, EnVivo Pharmaceuticals
2014 Consultant, Digital Psychiatry Educational Programs, Otsuka Americal Pharmaceuticals
2015 Consultant, National Football League
2015 Scientific Advisory Board, Schizophrenia, Forum Pharm. Boston, Mass.
18
18
CURRICULUM VITAE - PART II
Teaching Services
University of California, San Francisco 1968-78:
1975-1978 Director of Medical Student Education, Dept. of Psychiatry:
First Year Medical Students
1969-1970 (a) Behavioral Science and Psychopathology, Seminar Leader, Winter, 2 hrs/wk. Lecture,
"Psychophysiologic Disorders," given to entire class
1970 (b) Basic Clerkship 1-A. Supervisor, 2 hrs/wk, Spring
Second Year Medical Students
1968-1969 a) Psychiatry 121, Basic Psychiatry. Seminar Leader, 3 hrs/wk, Spring, Fall, Winter
1969-1970 b) Psychiatry 18, Behavioral Science and Psychopathology. Seminar Leader, 3 hrs/wk,
Fall Quarter; 2 hrs/wk, Spring Quarter, 1969-70. Course Coordinator, Spring, 1970
1972 c) Psychiatry 100, Psychopathology Course Committee, Course Coordinator and
Lecturer, 6 hrs/wk, Winter, 1972
1972 d) Psychiatry 101, Psychopathology Course Committee, Course Coordinator and
Lecturer, 6 hrs/wk, Winter, 1972
1973-1977 e) Psychiatry 100-101, Introduction to Clinical Psychiatry:
1972-73 Course Committee and Lecturer, 6 hrs/wk, Fall-Winter
1973-74 Course Coordinator and Lecturer, 6 hrs/wk, Fall-Winter
1974-77 Course Supervisor and Lecturer, 6 hrs/wk, Winter-Spring; Lecturer
Third Year Medical Students
1968- a) Psychiatry 110, Clinical Clerkship in Psychiatry. l hour/week, 1968-present;
Acting Director, Fall, 1977-78
Fourth Year Medical Students
1968-1978 a) Psychiatry 110, Clinical Clerkship in Psychiatry. 1 hour/week
1970-1975 b) Behavioral Specialist Pathway, Clinical Subpathway, Individual and Family
Therapy. Coordinator, 1 hour/week, Summer, Fall, Winter, Spring, 1970-75
Residents, Department of Psychiatry
1968-1978 a) Basic Psychiatry 1. Seminar Series Participant
1968-1978 b) Supervisor, 1st, 2nd, 3rd, and 4th Year Psychiatry Residents
1968-1978 c) Seminar on Hospital Psychiatry to Psychiatric Residents. 1 hour/week
19
19
1970-1972 d) Seminar, Family Dynamics and Therapy. 3 hrs/wk, Fall, ‘70; Spring, ‘71; Spring, ‘72
1969-1970 e) Clinical Psychiatry for Non-Psychiatrists. 2 hrs/wk, Fall-Winter
1968-1970 f) Paramedical Staff. 5 hrs/wk
1970 g) Committee to conduct qualifying examinations for admission to candidacy for PhD
degree, B. Tesher, Nursing, in the field of family therapy
1972-1973 h) The Teaching-Learning Process in Psychiatry. To Psychiatric Residents, Fall-Winter,
2 hrs/wk.
1973-1978 i) Coordinator, Basic Psychiatry II, to all Second Year Psychiatric Residents
1974-1977 j) Core seminar, Theory & Practice of Family Therapy, as part of Basic Psychiatry II, to
all second year psychiatric residents, 1974-75, 1975-76,1976-77 with David Kessler, MD
1976-1977 k) Seminar on Clinical Research Design, Elective, Third Year Psychiatric Residents
Cornell University Medical College - 1978-1993:
First Year Medical Students
1979 a) Understanding Human Behavior, Preceptor, 10 weeks, Fall
1980 b) Understanding Human Behavior, Lecturer and Panelist, Fall
1982 c) Investigative Approaches of Human Behavior, Preceptor, Spring
Third Year Medical Students
1978 a) Psychological Assessment of Medicine, Preceptor, Spring
1978 b) Core Clerkship, Preceptor, Summer
Other
1980-1993 a) Faculty Advisor
1980-1981 b) Internship Advisor
Faculty and Staff -- Department of Psychiatry
1978 a) Family Therapy Supervisory Seminar for Payne Whitney Faculty, 9 weeks, Spring
1978 b) Family Therapy Supervisory Seminar for Westchester Division Faculty, 9 weeks, Fall
1978 c) Seminar on Intro to Psychiatric Research for Payne Whitney Staff, 2 weeks, Fall
Residents: Department. of Psychiatry
20
20
Research Courses:
1980-1983 a) Introduction to Research, PGY II's, April-June
1980-1986 b) Intermediate Research Course, PGY lll’s, 10 weeks, January-April
1980-1986 c) Advanced Research Seminar, PGY IV's, 10 weeks, April-June
Psychopharmacology Courses
1982- a) Psychopharmacology Rounds, PGY II, III & IV's, 1982-present; Coordinator 1987-89
b) Psychopharmacology Consultant, to Inpatient Services, 1986-88, 1991-1993
1990-1993 c) Outpatient Psychopharmacology , PGY III's, 1990-present, weekly, all year
1990-1993 d) Psychopharmacology Supervision, PGY III's & IV's
Family Therapy Courses
1978-1993 a) Seminar on The Family Interview, PGY II Summer Course
1978-1993 b) Family Therapy-Inpatient Introductory Course, as part of PGY II Core Curriculum, 8 wks.
1979-1993 c) Family Therapy-Outpatient, for PGY III's as part of the Core Curriculum, Intermediate
Course, 8 weeks, Winter
1985-1993 d) Family Therapy, for PGY IV's, as part of Continuous Case Conference, Payne Whitney
Clinic, 12 weeks, Fall
1978 e) Seminar on Evaluation of the Family, as part of the Summer Orientation for PGY I's and II's
and Psychology Interns, Westchester Division, Summer
1978-1985 f) Introduction to Family Therapy, as part of Core Curriculum PGY II's, Westchester Division,
8 weeks (90 min.), Winter
1978-1980 g) Continuous Case Conference on Family Therapy, for the Child Psychiatry Service.
Bimonthly, September to June
Hospital Psychiatry Courses
1978-1993 a) Criteria for Selection of Inpatient Treatment Modalities, as part of PGY II Core Curriculum.
6/hours/yearly
b) Inpatient Psychiatry, for PGY II's, 3 weeks, Summer, (yearly).
1980-1984 c) Assistant Unit Chief Clinical Rounds, PGY IV's, Payne Whitney Clinic, biweekly
1991- d) Psychopathology Course, Schizophrenia to PG II's
General Psychiatry Courses
1978-1993 a) Psychiatric Resident Tutorial, Payne Whitney Clinic, 6/hours/yearly
1980-82 b) Supervisor, Long Term Psychotherapy, PGY II's
21
21
Stanford University School of Medicine - 1993 - present:
General Psychiatry Courses
1993-94- a) Psychopathology course, PGY II, Treatment Modules on Schizophrenia & Bipolar Disorder
1994-95- b) PGY IV Board Review Course, Schizophrenia Module
1993-98 c) Chairman's Rounds
Hospital Psychiatry Courses
1993- a) Inpatient Medical Student and Resident Supervision
1994-98 b) Inpatient Psychiatry, Course Coordinator and Lecturer, PGY II
• Overview
• Workup and Treatment Planning
• Treatment of Psychosis
Psychopharmacology Courses
1994 Introduction to Psychopharmacology, PG II,
2002 -Personality Disorder
2003 - Bipolar Disorder, Medication and Compliance Issues
1995---2013 Strategies of Outpatient Psychopharmacology, PG III, Course Coordinator and lecturer:
• Schizophrenia
• Combining & Integrating Psychotherapeutic Intervention with Medication
• Art of Psychopharmacology
2014-15- , Lecturer:
- Comparative Effectiveness Studies: Schizophrenia
-Emerging Antipsychotics and Off-Label Use of Antipsychotics
-Ethical Issues in Psychopharmacology
2004 Neuroscience, PG III
Lecture, Metabolic Side Effects of Antipsychotics
2005--2013 Introduction to Psychopathology and Psychopharmacology, PG II, 4 quarters/year, Course
Director (with Sara Mueller, MD and Sallie DeGolia, MD) and Lectures:
• History of Psychiatric Treatments
• Personality Disorders
2011- Overview of Psychiatry, PGY I
Lecture, Schizophrenia
Medical School Courses
Winter, 2001-02, Medical School Clerkship, Psychotic Disorder and Neuroleptic Treatment.
Outside UCSF, Cornell University Medical College & Stanford University
22
22
1965-1966 Columbia University, College of Physicians and Surgeons. Basic Clinical Psychiatry, to Third
Year Medical Students, Fall-Winter, 3 hrs/wk.
1964-1966 Hillside Hospital. Supervision and Teaching, First and Second Year Psychiatric Residents,
15 hrs/wk, all year.
1966-1968 U.S. Army Hospital Specialized Treatment Center. Ft. Gordon, Georgia. Basic Psychiatry I,
to Medical and Paramedical Staff, l hr/wk, all year.
1966-1968 Medical College of Georgia. Family Therapy, to Psychiatry Dept. Staff, Residents, and Medical
Students, 2 hrs/wk, 20 wks/yr
1970-1978 Mt. Zion Hospital and Medical Center. Seminar in Psychopharmacology, Psychosomatic
Conference, to Second and Third Year Psychiatry Residents, two 90-minute sessions yearly
1986 School of Medicine, University of Verona. Seminar on Recent Developments in American
Psychiatry, to Psychiatric Residents and Faculty, January-June, six 90 minute sessions
23
23
COMMITTEE SERVICE
University Of California, San Francisco, School of Medicine
Department of Psychiatry Committees:
1968-1970 Chairman, Public Health and Safety Committees, Langley Porter Institute
1968-1970 Research Committee, Clinical Research Ward, Langley Porter Institute
1969 Course Committee, Freshman Psychiatry Course, Dept. of Psychiatry
1969 Annual Graduation and Departmental Meeting, Langley Porter Institute
1969-1970 Ad Hoc Committee on Residency Training, Langley Porter Institute
1969-1978 Course Committee, Sophomore Psychiatry Course, Dept. of Psychiatry
1970 Ad Hoc Committee on Outpatient Psychiatric Care, Dept. of Psychiatry
1971-1973 Residency Selection Committee, Langley Porter Institute
1971-1973 Residency Training Committee, Langley Porter Institute
1972 Noon Conference Committee, Langley Porter Institute
1973 Building Committee, Langley Porter Institute
1973-1978 Departmental Committee on Medical Student Education, Dept. of Psychiatry
1973-1976 Review Committee for Appointments and Promotions of Regular Faculty, Dept. of Psychiatry
1974-1975 Staff Affiliate Review Committee, Langley Porter Institute
1974-1978 Committee on Academic Affairs, Dept. of Psychiatry, School of Medicine, UCSF
1975-1978 Departmental Task Force on Revision of Medical Student Curriculum, Dept. of Psychiatry
1976-1978 Administrative Planning Team, Langley Porter Institute
1976 Ad Hoc Committee for Alexander Simon Award, Dept. of Psychiatry
1976 Subcommittee for Basic Curriculum, Residency Training, Dept. of Psychiatry
1976-1978 Interdisciplinary Education Committee, Dept. of Psychiatry, School of Medicine
1976-1978 Medical Student Education Committee, Dept. of Psychiatry, School of Medicine
School of Medicine Committees
1973-1978 Curriculum Committee
1974-1978 Subcommittee on Evaluation
1974-1975 Basic Clinical Course Operations Subcommittee1974; Acting Chairman, 1975
1974 Screening and Promotions Committee
1975-1976 Search Committee, Director of Psychiatric Nursing, 1975-76
Cornell University Medical College:
Department of Psychiatry Committees
1978-1988 Inpatient Steering Committee
1978-1980 PGY II Education Committee
1978-1993 Family Therapy Planning Group, 1978-1993
1979-1983 PGY IV Education Committee
1978-1993 Departmental Research Committee- Chairman, 1981-83; Steering Committee, 1992-1993
1981-1983 Computer Committee
1981-1983 Media Committee
1983-1988 Residency Training Committee
1991-1993 Residency Training Committee
1985-1988 Fellowship Selection Committee
1984-1986 Space Committee
1987-1988 Executive Committee
1990-1993 Executive Committee
1990 Task Force on Vertical Services
24
24
1990-1993 Formulary Committee
1990-1993 Appointments and Promotions Committee
Stanford University School Of Medicine:
Departmental Committees
1993-2000 Executive Committee
1993- Residency Training Committee
1993-95 Credentials Committee, Chairman
1996-2005 Appointment & Promotions
Chair, 1999 – 2005
Hospital Committees
1993-2000 Inpatient Management Committee
1993-2000 Operations Improvement Committee
1993-2000 Psychiatry Business Plan Committee
1993-2000 Clinic Executive Committee
1998-2000 UCSF/Stanford Merger -
Brown & Toland Medical Group Mental Health Executive Committee
Mentoring
2008-9 Jacob S. Ballon, M.D., American Psychiatric Institute for Research & Education
(APIRE)
25
25
Curriculum Vitae – Part III COMMUNITY AND PUBLIC SERVICE
Presentation of paper "Psychophysiologic Factors in the Etiology of Preeclampsia," American Psychosomatic
Society, April 1964.
Grand Rounds, "Psychophysiologic Factors in the Etiology of Schizophrenia," to the Dept. of Psychiatry, Mt. Zion
Hospital, San Francisco 1964.
Grand Rounds, "Psychophysiologic Factors in the Etiology of Schizophrenia," to the Dept. of Obstetrics and
Gynecology, Mt. Zion Hospital, 1964.
Presentation of paper, "Mood and Behavioral Changes Associated with the Use of the Oral Contraceptive Agents:
A Review of the Literature," Eighth Annual Psychiatric Research Society Meeting, 1965.
Presentation of paper, "The 'Sick' Family and Schizophrenia - Cause and Effect?" to the Tenth Annual Psychiatric
Research Society Meeting, Cincinnati, 1967.
Institute Leader, "Family Dynamics and Treatment," Annual Meeting, Georgia Branch, National Association of
Social Workers, February 1967.
Invited Lecture, "The Place of Occupational Therapy in Clinical Psychiatric Treatment," Georgia Occupational
Therapy Association, 1967.
Institute Leader on "Family Therapy and Hospital Psychiatry," at Columbia, S.C., VA Hospital September 1967
Invited Lecture, on "The School and the Family," to the Annual Meeting of the Georgia Association of Visiting
Teachers, Augusta, Georgia, November 1967.
Seminar Leader on "Family Therapy," at Macon, Ga., Mental Health Clinic, Macon, Ga., November 1967.
Invited Address, "The Changing Role of the Family," Unitarian Fellowship, Augusta, Ga., December 1967.
Invited Lecture, "Basic Clinical Psychiatry" to Psychology Students, Paine College, Augusta, Ga., (Jan)1968.
Lecture and Panel Discussion, "The Role of the Clergy in Family Counseling, at a seminar on Family Counseling,
Augusta, Ga., February 1968.
Address, "The Family and Southern Society," to First Mt. Moriah Baptist Church, Augusta, Ga., April 1968.
Film Presentation: Videotape Playback in Family Therapy (with G. Marshall) 16mm. B & W 10 min. Presented at
the 1968 annual meeting, American Psychiatric Association, Boston, Mass. May 16, 1968
Grand Rounds, "Mood and Behaviorial Changes Associated with Use of Oral Contraceptives," OBGYN, University
of California, San Francisco, September 1968.
Participant, panel on Training of Family Therapists, Don D. Jackson Memorial Family Conference, Asilomar,
California, February 1969.
Lecture on "Current Status of Family Therapy," given to Association of Family Therapists, San Francisco, 3/69.
Film and Seminar Discussion on "An Introduction to Family Therapy," given at the Clinical Seminar Series, Langley
Porter Neuropsychiatric Institute, Psychology Dept., March 1969.
26
26
Two-Day Seminar on Current Developments in Psychiatry given at Dept. of Psychiatry, Medical College of
Georgia, May 1969.
Film "Family Therapy: An Introduction," presented at the Annual Meeting, American Psychiatric Association, Miami
Beach, Fla., May 1969.
Discussion of paper entitled "Psychosexual Responses to Ileostomy and Colostomy" at American Psychiatric
Association Meeting, Miami Beach, Fla., 1969.
Film "Family Therapy: An Introduction," shown at Staff Meeting, Mental Research at Ninth Western Divisional
Meeting 1969, of Westen Psychiatric Association, Seattle, August 1969.
Moderator of Panel on Family Therapy: Rationale, Methods, Teaching and Research at Ninth Western Divisional
Meeting 1969, of Western Psychiatric Association, Seattle, August 1969.
Discussion of Paper, "The Psychiatrist as Counselor and Friend to the Family," by Herbert C. Wimberger, MD, at
Ninth Western Divisional Meeting, Western Psychiatric Association, Seattle, August 1969.
Abstracts Editor, Family Process, July 1964-78.
Participant in CBS News Reports Program titled "The Pill," KPIX, February 1970.
Participant on Panel: "Therapists and Families," American Orthopsychiatric Association 47th Annual Meeting in
San Francisco, March 1970.
Lecture on "Issues in Family Therapy Training," presented to Interdisciplinary Training Program Seminar, Napa
State Hospital, May 1970.
Moderator of Panel, "Issues in Training of Family Therapists," American Psychiatric Association Annual Meeting,
May 1970.
Discussion Leader, NIMH Career Teachers in Psychiatry Meeting, Boston, October, 1971
Participant In Panel, "Emotional Problems of Psychiatric Residents," American Psychiatric Association Annual
Meeting, May, 1972.
Presentation of paper entitled "Management of Psychoses Associated with Dialysis," American Psychiatric
Association Annual Meeting, May 1972.
Regional Coordinator, "The Psychiatrist as Teacher," for the National Conference on Teaching Psychiatry, one-day
regional meeting held at San Francisco, May 1972.
Presentation of Paper and Participant on Panel, "Stress Events & Psychiatric Illness," at the
Symposium"Stress: Its Impact on Thought and Emotion," University of California at San Francisco, June 1972
Group Leader, Regional Coordinator, and Presentation at "Free University" of film on Family Therapy at the
national conference, "The Psychiatrist as a Teacher." Airlie House, October 3-6, 1972.
Lecture, "Transference and Countertransference," to Graduate Psychiatric Nursing Students, University of
California, San Francisco, November 1972.
Resource Teacher in Section on "University Dept. of Psychiatry" at the First National Conference on Training in
Family Therapy, Philadelphia, November 30 - December 2, 1972.
27
27
Lecture, "Depression," presented as part of a section entitled "Dilemmas in Therapy" as part of the 23rd Annual
Course for Physicians in General Practice, Mt. Zion Hospital and Medical Center, February 1973.
Presentation of paper, "Short vs. Long Hospitalization: A Prospective Controlled Study -- Preliminary Results of a
One-Year Follow-up of Schizophrenics," Research Seminar, Dept. of Psychiatry, Mt. Zion Hospital, April 1973.
Presentation of paper, "Short vs. Long Hospitalization: A Prospective Controlled Study -- Preliminary Results of a
One-Year Follow-up of Schizophrenics," at the Annual Meeting, American Psychiatric Association, Honolulu,
Hawaii, May, 1973.
Presentation of paper, "Indications and Relative Contraindications for Family Treatment, Circa 1973," at the San
Francisco Family Forum, San Francisco General Hospital, January 10, 1974.
Presentation of paper, "Treatment and Outcome in Schizophrenia," at the Merger Celebration in Honor of the Merger
of Langley Porter Neuropsychiatric Institute with University of California, San Francisco, February, 1974.
Presentation of paper, "Indications and Contraindications for Family Therapy," at the Nathan W. Ackerman
Memorial Conference, Venezuela, February, 1974.
Film presentation, "Family Therapy: An Introduction:" 1971: 12 showings 1972: 8 showings
1973: 8 showings 1974: 6 showings
Discussant, Conference, "Lithium: Its Role in Manic-Depressive Illness," Chief's Conference, Dept. of Psychiatry,
Mt. Zion Hospital, San Francisco, March 12, 1974.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization for Schizophrenia - Preliminary Results, One
Year Followup," Noon Conference, Langley Porter Neuropsychiatric Institute, San Francisco, 3/74.
Presentation of paper, "Mood and Behavioral Changes Associated with the Use of Oral Contraceptives," 1st World
Congress of Biological Psychiatry, Buenos Aires, Argentina, September, 1974.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," Dept. of Psychiatry
Grand Rounds, Cornell University Medical College, New York, NY, November 1974.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," SUNY, Downstate
Medical Center, New York, NY, November 1974.
Coordinator, "The Role of the Family in Medical Practice," Third National Workshop on Psychiatric Education,
Association for Academic Psychiatry, Chicago, Illinios, November 1974.
Presentation of paper, "Short Versus Long Hospitalization - A Prospective Controlled Study: One Year Followup
Results," Section on Interaction of Drugs and Nonsomatic Therapies, American College of
Neuropsychopharmacology, Puerto Rico, December 1974.
Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. IV-A. One Year
Followup Results for Schizophrenics," Research Conference, Dept. of Psychiatry, Mt. Zion Medical Center, San
Francisco, February 18, 1975.
Panel Discussant, "The Treatment of Schizophrenia at Langley Porter Institute," Noon Conference, Langley Porter
Institute, San Francisco, April 30, 1975.
Panel Moderator, "Controlled Studies of Alternative Lengths of Hospitalization for Psychiatric Illness," presented at
the 1975 Annual Meeting, American Psychiatric Association, Anaheim, California, May 1975.
28
28
Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. IV. One Year Followup
Results for Schizophrenics," American Psychiatric Association Annual Meeting, Anaheim, CA, 5/75.
Radio presentation, "Loxitane in Schizophrenia," CBS Radio Network, July 12 and 13, 1975.
Discussant, "Conceptual Approaches to Schizophrenic Disorder," Grand Rounds, Dept. of Psychiatry, University of
California, San Francisco, September 22, 1975.
Discussant, "Depression in Medical Practice," Grand Rounds, Dept. of Medicine, University of California, San
Francisco, September 23, 1975.
Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. II. Results for
Schizophrenic Inpatients," Langley Porter Institute weekly research staff conference, October 10, 1975.
Panelist, "Can a Psychiatric Hospital Survive Mental Health and Marijuana?" Grand Rounds, Dept. of Psychiatry,
UCSF, November 18 and 25, 1975.
Seminar Leader, "Issues in Family Therapy," California Branch District Meeting American Psychiatric Association
Conference, Palm Springs, November 1975.
Presentation of paper, "Short VersusLong Psychiatric Hospitalization: A Controlled Study. Medication and Outcome
for Schizophrenics," American College of Neuropsychopharmacology, Puerto Rico, December 1975.
Exhibit, entitled "A Teaching Package for a Preclinical Psychiatry Course," 30th All-University Faculty Conference,
University of California, Santa Barbara, March 25-27, 1976.
Discussant and Presentation of paper, "Short Versus Long Psychiatric Hospitalization," as part of a
symposium: "A Critical Appraisal of Community Psychiatry," Kittay Scientific Foundation, NY, 3/76.
Presentation of paper, "Controversial Premises of Marital and Family Therapy," (with David R. Kessler, MD) for the
San Francisco Family Forum, Family Health Center, San Francisco General Hospital, April 15, 1976.
Presentation and Discussion, "Short Versus Long Psychiatric Hospitalization: A Controlled Study, Two Year
Results," Grand Rounds, Dept. of Psychiatry, UCSF, April 20, 1976.
Panelist, "Schizophrenia -- Which Treatment and For Whom," 1976 Annual Meeting, American Psychiatric
Association, Miami, May 1976.
Panelist, "What Makes Medical Students So Difficult To Teach?" 1976 Annual Meeting, American Psychiatric
Association, Miami, May 1976.
Panelist, "Controversies in Psychiatric Education," 1976 Annual Meeting, American Psychiatric Association, Miami,
May 1976.
Presentation of paper, "Increasing Learning During the Psychiatric Residency," (with Leon Epstein, MD) 1976
Annual Meeting, American Psychiatric Association, Miami, May 1976.
Presentation of paper, "Indications and Contraindications for Family Therapy; Changing Concepts," Psychiatry
Grand Rounds, Dept. of Psychiatry, School of Medicine, U.C. Davis, September 1976.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study: Two Year Results,"
Dept. of Psychiatry, Mt. Sinai School of Medicine, New York, September 1976.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization: Final Results and Treatment Implications,"
Dept. of Psychiatry, Mt. Zion Hospital and Medical Center, San Francisco, October 1976.
29
29
Keynote Speaker, "Short-Term Intensive Psychiatric Hospital Treatment: Which Treatment and for
Whom?" National Conference on Short-Term Intensive Psychiatric Hospital Treatment, Scottsdale, AZ, 11/76
Panel Moderator, "Treating the Impaired Physician: Confidentiality vs. Responsibility," presented at the 1976
Annual Meeting, Association of American Medical Colleges, San Francisco, November 1976.
Examiner, American Board of Psychiatry and Neurology, Seattle, February 1977.
Special Lecture, "A Teaching Package for a Preclinical Psychiatry Course," Dept. of Psychiatry, College of
Physicians and Surgeons, Columbia University, New York, February 1977.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," Grand Rounds, Dept.
of Psychiatry, University of New Mexico, Albuquerque, New Mexico, March 1977.
Presentation of paper, "Indications and Contraindications for Family Therapy," Grand Rounds, Veterans
Administration Hospital, Albuquerque, New Mexico, March 1977.
Referee, Journal of Nervous and Mental Diseases, Archives of General Psychiatry, American Journal of
Psychiatry, and Family Process. Hospital and Community Psychiatry.
Presentation of paper, "The Architectural Design of a Psychotherapeutic Milieu," 1977 Annual Meeting of the
American Psychiatric Association, Toronto, Canada, May 1977.
Panelist, "New Directions in Family Research: Ritual, Real Time and Images," 1977 Annual Meeting of the
American Psychiatric Association, Toronto, Canada, May 1977.
Panel Moderator, "Schizophrenia - Which Treatment and For Whom?", 1977 Annual Meeting of the American
Psychiatric Association, Toronto, Canada, May 1977.
Panelist and Discussion Group Leader, at conference entitled "Families In Contemporary America: Varieties of
Form, Function and Experience," jointly sponsored by the Dept. of Psychiatry and Behavioral Sciences of the
George Washington University School of Medicine and the Center for Continuing Education in Mental Health of
the Psychiatric Institute Foundation, Washington, D.C., June 1977.
Television Presentation, Role of Clinical Psychiatry - on "The Hidden Universe" - ABC National Television
Documentary, June 1977.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization," World Psychiatric Association, Honolulu,
August 1977.
Presentation of paper, "Indications and Contraindictions for Family Therapy," as part of an invited seminar on
Family Therapy, World Psychiatric Association, Honolulu, August 1977.
Advisory Editorial Board Member, International Journal of Family Therapy, as of September 1977. Psychiatric
Quarterly, 1980.
Discussant, "The Premenstrum: A Psychological Investigation," Grand Rounds, Dept. of Psychiatry, University of
California, San Francisco, November 22, 1977.
Presentation of paper, "Development of a Curriculum and of a Faculty for Medical Student Education in
Psychiatry," The Annual Meeting of the Association of Academic Psychiatry, New Orleans, January 1978.
Presentation of paper, "A New Drug Treatment for Premenstrual Psychosis," Poster Session, The Annual Meeting
of the American Psychiatric Association, Atlanta, Georgia, May 1978.
30
30
Organizer, Special Session, "Treating the Impaired Physician: Confidentiality and Responsibility," The Annual
Meeting of the American Psychiatric Association, Atlanta, Georgia, May 1978.
Presentation of paper, "Hospitals in the 1980s: Service, Training and Research," Presented as part of the Special
Session, "Hospital Treatment of Emotional Disorders: Circa, 1978, at the Annual Meeting of the American
Psychiatric Association, Atlanta, Georgia, May 1978.
Lecture and Discussion, "Indications and Contraindications for Family Therapy: Circa, 1978," at Grand Rounds,
Dept. of Psychiatry, The New York Hospital-Cornell University Medical College, May 17, 1978.
Presentation of paper, "Research in Occupational Therapy," at a Conference entitled, "A Revitalization Movement
within Occupational Therapy" sponsored by Metropolitan New York District, New York State Occupational Therapy
Association. May 1978.
Presentation and Discussion, "Family Therapy & Crisis/Loss,"Memorial Hospital, New York, November 2, l978.
Presentation and Discussion, "The Hospital Management of the Suicidal Patient," at a Symposium: "The Suicidal
Patient: Identification and Treatment," sponsored by Dept. of Psychiatry, Albany Medical College, March 28, 1979,
Albany, New York.
Presentation and Discussion, "Psychiatric Problems in General Practice," as part of a Symposium: "Common
Medical Problems in Office Practice," sponsored by the Continuing Education Committee of St. Vincent's Hospital,
Santa Fe, N.M., March 30, 1979.
Presentation and Discussion, "Effects of Divorce on the Family," as part of a Symposium, "Divorce and the
Patient," Sponsored by Continuing Education Committee of St. Vincent's Hospital, Santa Fe, N.M., 3/79.
Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study -- Final Results," Grand
Rounds, McLean Hospital, Boston, Massachusetts, April 1979.
Presentation of paper, "A New Drug Treatment for Premenstrual Exacerbation of Schizophrenia" at Harvard
Medical School, Dept. of Psychiatry, Boston, Massachusetts, April 1979.
Presentation of paper, "The Physician's Family: Approach to Impairment," as part of a Symposium, "The Impaired
Physician: Prevention and Treatment," at the Annual Meeting, American Psychiatric Association, Chicago, May
1979.
Discussant, "Psychotherapy Supervision," at the American Psychiatric Association's Annual Meeting, Chicago,
May 1979.
Presentation, "Short Hospital Stay is Better than Long Hospital Stay?" "Pro Position" at the 31st Institute on
Hospital and Community Psychiatry, September 3-6, 1979, New Orleans.
Presentation, "Future Directions in Hospital Psychiatry," keynote speech, Dept. of Psychiatry, at Alumni Teaching
Day, Long Island Jewish-Hillside Medical Center, Glen Oaks, New York, September 1979.
Grand Rounds, "The Family Model in an Inpatient Setting," Dept. of Psychiatry, North Shore Hospital, Manhasset,
New York, October 1979.
Grand Rounds, "The Family Model in an Inpatient Setting," Dept. of Psychiatry, Albert Einstein College of
Medicine, New York, NY, October 1979.
Grand Rounds, "Family Therapy -- Indications and Contraindications," Dept. of Psychiatry, City Hospital Center at
Elmhurst, October 1979.
31
31
Grand Rounds, "Psychiatric Hospitalization for the 1980s: A Controlled Study of Short Versus Long Hospitalization,
Final Results," Dept. of Psychiatry, Cornell University Medical College, April 1980.
Invited Paper, "Psychiatric Aspects of Basketball," Psychiatric Annals Volume 10, Number 3:108-112, 1980.
Organizer of Continuing Medical Education Seminar, titled, "Hospital Treatment: Which Treatment and How Long
for Which Patients?" Cornell University Medical College, Dept. of Psychiatry, April 1980.
Presentation on "The Role of Psychoanalysis in Family Therapy," as part of a Continuing Medical Education
Course entitled, "The Role of Psychoanalysis in Contemporary Psychiatry," at Cornell University Medical College,
Spring, 1980.
Discussant for Symposium, "Enhancing Treatment Compliance," at the Annual Meeting of the American
Psychiatric Association, San Francisco, 1980.
Presentation on "Leadership in the Hospital," as part of a Course on "Leadership," at the Annual Meeting of the
American Psychiatric Association, San Francisco, 1980.
Presentation on "Family Therapy and the Treatment of the Child" at the weekly Child-Adolescence Staff Meeting,
Dept. of Child Psychiatry, Mt. Sinai Hospital, November 1980.
Participant, on Radio Program, "Conference Call: Parents & Children, WABC, November 30, 1980, New York.
Grand Rounds, "Psychiatric Hospitalization for the 80s," St. Joseph's Hospital and Medical Center, Paterson, New
Jersey, February 1981.
Keynote Speaker, "Illness and the Impact on Family Systems," at a Symposium entitled "Illness and the Family,"
sponsored by La Tortuga & Sherman Clinic, Santa Fe, March 198l.
Presentation of paper, "Thinking Disorder in Depression: Longitudinal Results" (with Braff D, Griffin P), and
"Outcome of Irregularly Discharged Mental Patients" (with Braff D, Johnson G), for the American Psychiatric
Association Annual Meeting, New Orleans, May 1981.
Consultant for Departmental Planning, Dept. of Psychiatry, Mt. Zion Hospital, San Francisco, CA , June 1981.
Chapter Consultant, Family Therapy, American Psychiatric Assn. Commission on Psychiatric Therapies, 1981.
Grand Rounds, "Short Vs Long Hospitalization: Final Results," State University of New York, Syracuse, NY, 9 /81.
Grand Rounds, "Treating the Hospitalized Schizophrenic Patient and Family," Rockland Psychiatric Center,
Orangeberg, New York, October 1981.
Presentation, "Short Versus Long Hospitalization for Schizophrenia," World Psychiatric Association/APA Regional
Meeting, New York City, November 1981.
Chairman, Education Committee and session on the "Teaching of Psychopharmacology," Annual Meeting,
American College of Neuropsychopharmacology, San Diego, December 1981.
Presentation, "The Family Model in an Inpatient Setting," Family Study Group, SUNY, Downstate Medical Center,
January 1982.
Presentation of paper, "Duration of Hospitalization as a Variable in Outcome," (John F. Clarkin, PhD and Ira
D. Glick, MD), The National Association of Private Psychiatric Hospitals, Scottsdale, Arizona, January 1982.
32
32
Panelist, "Family Therapy of Suicidal Behavior," Annual Meeting of Assn. of Suicidology, New York City, 4/82.
Presentation of paper, "Thought Disorder and Depression in Psychiatric Patients," (David L. Braff, MD and Ira
D. Glick, MD) for the Western Psychological Association Annual Meeting, Sacramento, CA, April 1982.
Panelist, "The Widening Scope of Family Therapy," Annual Meeting of the American Psychiatric Association,
Toronto, Canada, May 1982.
Presentation of paper, "Which Chronic Patients Mostly Need Readmission," (with Braff D, MD, Klar H, MD), for the
Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 1982.
Discussant, Conference on "The Changing American Family," The 67th Annual Seymour Silverberg Lecture, Long
Island Jewish-Hillside Medical Center, June 1982.
Keynote Address, "Couples in the 1980s: Emerging Trends," Workshop on "Step-Parenting," and Panel
Discussion - all at the Symposium, "Marital and Sexual Therapy," The Family and Couples Institute, The Dept. of
Psychiatry, Tufts University School of Medicine, Boston, June 1982.
Presentation of Research Project, "Inpatient Family Intervention: A Controlled Study" and Presentation of "The
Family Therapy Training Program at PWC" at the 1982 Annual Meeting, American Family Therapy Association,
Boston, June 1982.
Invited Guest, Interviewed on topic of "Vacations & Couples," on Travel Talk, Dena Kaye, WMCA, NYC, 10/82.
Invited Lecturer, "The Changing American Family: Emerging Trends and Comparison with the Japanese Family,"
Dept. of Psychiatry, Juntendo University, Tokyo, October 1982.
Grand Rounds, "Toward the Definition and Delivery of Mental Health Care," Massachusetts Mental Health Center,
Boston, October 1982.
Grand Rounds, "Guidelines for Family Therapy," Dept. of Psychiatry, Medical College of Georgia, 1/83.
Grand Rounds, "Guidelines for Family Therapy," Dept. of Psychiatry, Tulane University and Louisiana State
University, February 1983.
Presentation of paper, "Teaching Investigative Psychiatry to Psychiatric Residents, a Sequential
Curriculum: Everything You Wanted to Know About Research, But Were Afraid To Ask." Free University
Presentation, at the Annual Meeting of the Association for Academic Psychiatry, Tampa, March 1983.
Presentation of paper, "A New Drug Treatment for Premenstrual Schizophrenia," at the Eleventh Annual
Conference on Psychosomatic Obstetrics and Gynecology, Sugar Loaf, Temple University Conference Center,
Philadelphia, March 1983.
Visiting Scholar, Dept. of Psychiatry, School of Medicine, University of Vermont, Burlington, March 1983.
Grand Rounds, "Psychiatric Hospitalization for the 1980s," Dept. of Psychiatry, School of Medicine, UCLA and
Harbor Hospital, Los Angeles, April 1983.
Grand Rounds, "Toward the Definition and Delivery of Mental Health Services: Who Should Pay and for What?"
Dept. of Psychiatry, UCSF, San Francisco, April 1983.
Invited Paper, "Treatment of Severe Premenstrual Syndrome (PMS) and Premenstrual Exacerbation of Psychiatric
Disorder," Premenstrual Syndrome Workshop, co-sponsored by Center for Studies of Affective Disorder,
Psychobiological Processes & Behavioral Medicine Section, Clinical Research Branch, and the Intramural
Research Program, NIMH, April 1983.
33
33
Presentation, "Treatment of Dual Doctor Couples," as part of an APA Issue Workshop, "Dual Doctor Couples" at
the Annual Meeting of the American Psychiatric Association, New York, May 1983.
Co-Chair and Presentation, "Overview" for Component Presentation, "Obstacles to Quality Clinical Systems,"
presented by APA Committee on Administrative Psychiatry, at the Annual Meeting of the American Psychiatric
Association, New York, May 1983.
Presentation and Co-Moderator, APA Issue Workshop, "Family Therapy Training in Residency Programs," at the
Annual Meeting of the American Psychiatric Association, New York, May 1983.
Presentation, "The Basics of Family Treatment" (with Henry Grunebaum, MD), as part of "Psychiatry
Update," at the Annual Meeting of the American Psychiatric Association, New York, May 1983.
Presentation, "Review of Length of Stay Research," as part of a course, "Inpatient Treatment Programs:
Programs: Acute and Long-Term," at the Annual Meeting of the American Psychiatric Association, NY, 5/83.
Presentation of paper, "The Importance of Thought Disorder in Depressives" (with David Braff, MD), at the Annual
Meeting of the American Psychiatric Association, New York, May 1983.
Presentation of paper, "Inpatient Family Intervention: A Controlled Study," at the Annual Meeting of the American
Psychiatric Association, New York, May 1983.
Presentation of Research Project, "Inpatient Family Interventions: A Controlled Study" and Presentation of "The
Family Therapy Training Program at PWC" at the 1983 Annual Meeting, American Family Therapy Association,
San Francisco, California, June 1983.
Grand Rounds, "Psychiatric Hospitalization for the 1980s," Bergen Pines County Hospital, Paramus, NJ. 6/83.
Presentation, "Inpatient Family Intervention: A Controlled Study," at the Annual Meeting of the American
Psychological Association, Anaheim, California, August 1983.
Grand Rounds, "When Should the Chronic Patient be Hospitalized," Dept. of Psychiatry, St. Luke's/Roosevelt
Hospital Center, New York, September 1983.
Distinguished Lecturer, "Doing Research Without Pain," University of Medicine and Dentistry of NJ, 101/83.
Lecture, "Diagnosis and Treatment of Depression," as part of a course, "Recent Advances in Medicine," Temple
University School of Medicine, Philadelphia, November 1983.
Co-Chairman, ACNP Training Session, "Issues in Clinical Psychobiologic-Psychopharmacologic Research
Training," Annual Meeting of the American College of Neuropsychopharmacology, San Juan, 1983.
Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services - Who Should Pay and for
What?" The New York Hospital-Cornell University Medical College, January 1984.
Grand Rounds, "The Changing Role of the Hospital in Treatment of the Chronic Patient," Roosevelt Hospital, New
York, February 1984.
Invited Lecturer, "Focus on Family Psychotherapy Advances" and "Practical Office Psychotherapy," Winter
Update, Dept. of Psychiatry, University of South Dakota, February 1984.
Free University Presentation, "Teaching Integration of Psychiatric Models to Residents," at the Annual Meeting of
the Association of Academic Psychiatrists, Tampa, March 1984.
34
34
Grand Rounds, "Diagnosis and Treatment of Depression" at Grand Rounds, in Dept. of Psychiatry in 5 settings,
1983-84.
Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services: Why Don't Patients Receive
Appropriate Care?" Dept. of Psychiatry, Mt. Sinai, April 1984.
Invited Lecture, "Towards the Definition of and Delivery of Mental Health Services: Why Don't Patients Receive
Appropriate Care?" Dept. of Psychiatry," The University of New Mexico, April 1984.
Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services," Dept. of Psychiatry, College of
Physicians and Surgeons of Columbia University, April 1984.
Grand Rounds, "Psychiatric Hospitalization for the 1980s," Dept. of Psychiatry, New York Medical College,
Valhalla, New York and Metropolitan Hospital, New York City, May 1984.
At the Annual Meeting of the American Psychiatric Association, Los Angeles, May 1984:
Presentation, "Treatment of the Premenstrual Syndromes," as part of a Symposium, "Premenstrual
Syndrome: Current Findings and Future Directions."
Faculty, "Short-Term Psychosocial Inpatient Treatment," as part of a Course, "Short-Term
Psychiatric Treatment."
Leader of Discussion Group, "Delivering State-of-the-Art Multimodality Treatment."
Co-Chair and Presentation, "New Demographic Trends in American Marriage," (with Oliver
Bjorksten, MD and Thomas Stewart, PhD), as part of a Symposium, "New Clinical Concepts in Marital
Therapy."
Chairman and Presentation, "Inpatient Family Intervention: A Controlled Study, Preliminary
Results," (with J. Clarkin, PhD, G. Haas, PhD, J. Spencer, MD, et al), as part of a Symposium,
"Results of Family Treatment: Second Generation Studies."
Grand Rounds, "Is There Any Future for Long-Term Hospitalization?" Silver Hill Foundation, New Canaan, CT,
June 1984.
Grand Rounds, "Which Chronic Patients Most Need Readmission?" Norristown State Hospital, 9/94.
Visiting Lecturer, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University
of Chicago School of Medicine, September 1984.
Invited Lecturer, "Creativity and Madness," Annual Meeting, Louisiana Psychiatric Society, New Orleans, 9/84.
Invited Lecturer, "Guidelines for Family Therapy," Departments of Psychiatry, Tulane University and Louisiana
State University, October 1984.
Presentation, "The Family Model and the Treatment of Affective Disorders," at Albert Einstein Medical Center,
Northern Division, Philadelphia, October 24, 1984.
Grand Rounds, "Indications and Contraindications," Dept. of Psychiatry, Bronx Lebanon Hospital Center, 11/94.
Departmental Colloquia, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry,
University of Pennsylvania, December 1984.
Guest Speaker, "Trends in Marriage & Marital Therapy," South Jersey Psychiatric Society, Cherry Hill, N J, 12/84.
35
35
Co-Chair, ACNP Study Group, "Psychotropic Drug and Psychotherapy Interaction Research," Annual Meeting of
the American College of Neuropsychopharmacology, San Juan, 1984.
Co-Chairman, ACNP Training Session, "Proposed Curriculum for Teaching Psychopharmacology," Annual
Meeting of the American College of Neuropsychopharmacology, San Juan 1984.
Grand Rounds, "Guidelines for Marital and Family Therapy," Detroit Psychiatric Institute and Lafayette Clinic,
Detroit, January 1985.
Continuing Education Workshop, "Family Therapy - Working with Couples," Dept. of Continuing Education,
Harvard Medical School at New York City, January 1985.
Grand Rounds, "Why Don't Patient Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University of
Utah, Salt Lake City, February 1985.
Grand Rounds, "Diagnosis and Treatment of Depression," Coney Island Hospital, New York, February 1985.
Grand Rounds, "Inpatient Family Intervention: A Controlled Study - Preliminary Results," University of California,
San Francisco, February 1985.
Grand Rounds, "New Concepts About Inpatient Family Intervention for Psychiatric Disorders," Peninsula Hospital,
Hillsdale, California and San Mateo Hospital, San Mateo, California, March 1985.
Grand Rounds, "New Concepts in Family Intervention in Chronic Mental Illness," Harlem Valley Psychiatric Center,
Wingdale, New York, March 1985.
Grand Rounds, "Psychiatric Hospitalization for the 1980s: A Controlled Study of Short-Term Versus Long-Term
Hospitalization," Duke University Medical Center, Durham, North Carolina, March 1985.
Invited Faculty, "The `Shrinking' of Inpatient Psychiatry: What To Do About Limited Hospital Stays" and Workshop,
"Family Work on an Inpatient Unit," both as part of course at Harvard Medical School, Dept. of Continuing
Education, Boston, March 1985.
Grand Rounds, "Recent Trends in Marriage and the Family: Effects on Therapy," Tufts-New England Medical
Center, Boston, April 1985.
Grand Rounds, "The `Shrinking' of Hospital Psychiatry," Dept. of Psychiatry and the Behavioral Sciences, USC
School of Medicine, Los Angeles, April 1985.
Grand Rounds, "Inpatient Family Intervention: A Controlled Study," The Medical College of Pennsylvania,
Philadelphia, April 1985.
Grand Rounds, "The Family and Its Role in Diagnosis and Treatment of Depressive Disorder," Georgetown
University School of Medicine, Washington, D.C., April 1985.
Grand Rounds, "Psychoeducation in a Hospital Setting," Silver Hill Hospital, Silver Hill, Connecticut, 5/85.
Grand Rounds, "Guidelines for Marital and Family Therapy: Circa 1985," Dept. of Psychiatry, Stanford Medical
School, Palo Alto, California, May 1985.
At the Annual Meeting of the American Psychiatric Association, Dallas, May 1985:
Workshop, Presentation of "A Model Psychoharmacology Curriculum," (with David S. Janowsky, MD,
Richard I. Shader, MD and Carl Salzman, MD)
36
36
Presentation, "The Family and Antidepressant Noncompliance" (with John Clarkin, PhD and
Gretchen Haas, PhD) as part of a Symposium, "Resistance to Antidepressants: Psychosocial
Factors"
Presentation, "Quality Treatment and Practitioner Competence" as part of a Symposium, " Evaluation of
Knowledge and Practice in Psychiatry - Joint Session with the Association for Academic Psychiatry"
Study Group, "Residents with Marital Distress: The New Epidemic?"
Chairman and Presentation, "Inpatient Family Intervention: A Controlled Study," (with John Clarkin, PhD,
Gretchen Haas, PhD, James H. Spencer, MD, Alfred Lewis, MD and Joanne Newman, M.S.W.) as part
of a symposium "Results of Family Therapy Outcome Studies"
Faculty, "Short Term Psychosocial Inpatient Treatment," as part of a Course, "Short-Term
Psychiatric Treatment"
Workshop, "Family Therapy, Severe Psychiatric Problems and the Psychiatric Hospital:
Critical Issues at the Interface," as part of a series of workshops, "Family Therapy: The Master
Therapists," sponsored by Dept. of Psychiatry, University of Connecticut School of Medicine, 6/85.
Grand Rounds, "Diagnosis and Treatment of Depression," Dept. of Psychiatry, Bowman Gray School of Medicine,
Winston-Salem, North Carolina, August 1985.
Invited Address, "Survival for the Physician and the Family in the 1980s," Capital Medical Society, Tallahassee,
Florida, August 1985.
Grand Rounds, "Indications and Contraindications for Family Therapy," Dept. of Psychiatry, Emory University,
Atlanta, September, 1985.
Invited Presentation, "The Shrinking Of Hospital Psychiatry And What To Do About It," Annual Meeting, Hospital
Corporation of America, Orlando, December 1985.
ACNP Poster Presentation, "Inpatient Family Intervention: The Patient, the Family and Compliance with Drug
Treatment for Affective Disorders," December 1985.
Presentation of paper, "Inpatient Family Intervention: A Controlled Study" at the Annual Meeting of the American
Psychiatric Association, Washington, D.C., May, 1986.
Invited Lecture, "The Family and Recent Developments in Psychiatry," Family Institute of Milan, Italy, 3/86.
Visiting Professor, "`Family Therapy: Indications and Contraindications," Dept. of Psychiatry, School of Medicine
and Surgery, University of Naples, Italy, May, 1986.
Grand Rounds, "The Patient, the Family and Psychiatric Hospitalization," Dept. of Psychiatry, Jefferson Medical
College, Philadelphia, October, 1986.
Grand Rounds, "Psychiatric Hospitalization for the 1980's," Dept. of Psychiatry, Hahnemann University,
Philadelphia, October, 1986.
Grand Rounds, "Treating the Family of the Hospitalized Patient, Is it Worth It?" North Shore University Hospital,
New York, October, 1986.
Grand Rounds, "Combination Therapy: A Study of Inpatient Family Intervention," Westwood Lodge Hospital and
Pembroke Hospital, Boston, October, 1986.
37
37
Grand Rounds, "Receiving Effective Psychiatric Treatment," Albert Einstein Medical Center, PA, 11/86.
Grand Rounds, "Working With The Family - Is It Worth It? A Controlled Clinical Trial of Inpatient Family
Intervention", Dept. of Psychiatry, Cornell University Medical College and Payne Whitney Clinic, The New York
Hospital, November, 1986.
Grand Rounds, "New Developments in the Treatment of Schizophrenia: Combining Drug and Family Therapy,"
Dept. of Psychiatry, Lincoln Hospital, New York, November, 1986.
Grand Rounds, "Psychosocial Interaction in the Treatment of Schizophrenia," Dept. of Psychiatry, Coney Island
Hospital, Brooklyn, November, 1986.
At the Annual Meeting of the American College of Neuropsychopharmacology, Washington, D.C., 1986:
Co-Chair, ACNP Training Session, "Teaching Psychopharmacology in the 1990's"
Chair, Presentation of Paper, "The Teaching of Psychopharmacology in the United States"
ACNP Poster Presentation, "The Patient, the Family, and Compliance with Drug Treatment for
Affective Disorders"
At the Annual Meeting of the American Psychiatric Association, Chicago, Illinois, May, 1987:
Presentation, "Inpatient Family Intervention for Affective Disorders" as part of a Symposium,
"Depression and Families: Recent Advances"
Presentation, "Inpatient Family Intervention for Psychotic Disorders" as part of a Symposium,
"Advances in Family Psychiatry"
Presentation, "Study Design Influences Generalizability of Result" as part of a Symposium, "Long- Term
Treatment Strategies in Schizophrenia"
In Japan, lectures and other activities during sabbatical year, 1987:
1) New Directions in Family Therapy, School of Medicine, Kanazawa University, January.
2) Indications and Contraindications for Family Therapy, Kochi Medical School, Kochi City,Shikoko
3) The Psychoeducational Approach, Psychoanalytic Seminar, Keio University & Hospital
4) Indications and Contraindications for Family Therapy, Tokyo Community Counseling Service
5) The Family on the Move: Family Function and Problems, International School of the
Sacred Heart, Tokyo, April.
6) Diagnosis and Therapy of Depression, Dept. of Psychiatry, Tokai University, April.
7) Psychoeducational Treatment in Psychiatry, Okayama Prefectorial Mental Hospital, April.
8) Indications and Contraindications for Family Therapy, Psychiatric Research Institute of Tokyo
9) Hasagawa Hospital - April-June
a. New Concepts in Treatment of Schizophrenia
b. Psychoeducational Treatment in a Hospital Setting
c. Diagnosis and Therapy of Depression
10) The Changing American Family, Continuing Education Course, Japan NIMH
11) Indications and Contraindications for Family Therapy, Dept. of Psychiatry, School of Medicine,
Fukuoka University
12) Recent Trends in Treatment of Mental Patients, Dept. of Social Administration, Tokyo
Metropolitan Hospital
13) Indications and Contraindications for Family Therapy, Tokyo Family Therapy Association
38
38
14) The Changing American Family, Emerging Trends and Comparisons with the Japanese
Family, U.S. Information Service Seminar, Sapporo, Hokkaido
15) Combination Therapy in Modern Psychiatry, Keio Medical School
16) A Model Psychopharmacology Curriculum, Nihon University, Tokyo
17) The Changing American Family, Emerging Trends and Comparisons with the Japanese
Family, U.S. Information Service Seminar, Tokyo
18) Featured Guest, The Changing American Family, Japanese-American Cultural Program,
NHK - Educational TV
19) The Changing American Family, Emerging Trends and Comparisons with the Japanese
Family, U.S. Information Service Seminar, Nagoya
20) A Study of the Quality of Psychiatric Care - Preliminary Results, Staff Conference, Japan NIMH
Research Conference, "A Controlled Study of Transitional Day Care for Non-Chronically Ill Patients," Dept. of
Psychiatry, Cornell University Medical College and Payne Whitney Clinic, The New York Hospital, 9/87.
Grand Rounds, "Working with the Family of a Hospitalized Patient - Is It Worth It?" Dept. of Psychiatry, Brookdale
Hospital, Brooklyn, New York, September, 1987.
Clinical Conference, Grady Memorial Hospital and Emory Medical School, Atlanta, Georgia, October, 1987.
Invited Lecture, "Recent Advances in Psychiatry: The Family and Family Therapy," Prasat Neurological Hospital,
Bangkok, November, 1987.
Invited Lecture, "Recent Advances in the Treatment of the Psychoses," Dept. of Neurology & Psychiatry, Pra
Mongkutklao Army Hospital, Bangkok, November, 1987.
The Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, 12/87:
Study Group - Drug & Psychosocial Therapy in Schizophrenia and Affective Disorders, Co-Chair with
Nina Schooler, PhD
Presentation of Paper - Inpatient Family Intervention: Final Results for Schizophrenia and
Affective Disorder
Grand Rounds, "New Therapies in Depression: Combining Drugs & Psychotherapy," Pacific Presbyterian Medical
Center, San Francisco, January, 1988.
Guest Consultant, Biological Psychiatry Colloquium, "Clinical Management of a Treatment Resistant Patient with a
Bipolar Compulsive Disorder," Pacific Presbyterian Medical Center, San Francisco, January, 1988.
Grand Rounds, "Inpatient Family Interventions for Psychotic Disorders," South Beach Psychiatric Center, Staten
Island, New York, February, 1988.
Grand Rounds, "Inpatient Family Intervention: A Randomized Clinical Trial," Dept. of Psychiatry, Emory University
School of Medicine, Atlanta, Georgia, February, 1988.
Presentation, "How to Teach Family Therapy and (Even, Sometimes) Succeed," (with Alan Manevitz, MD), Annual
Meeting of the Association for Academic Psychiatry, Free University Section, Tampa, Florida,3/88.
Presentation & Workshop, "The Interface of Psychodynamic Psychotherapy and Psychopharmacology" 10th
Annual Menninger Foundation Winter Conference, Park City, Utah, March, 1988:
39
39
The Annual Meeting of the American Psychiatric Association, Montreal, Canada, May, 1988:
Presentation, "The Family and Schizophrenia" as part of a Symposium, "Psychosocial Treatment of
Schizophrenia" with James Spencer, MD, Gretchen Haas, PhD, John Clarkin, PhD, et al
Presentation, "Inpatient Family Intervention: Follow-up Results" as part of a Symposium, "Psychotherapy:
Process and Outcome" with James Spencer, MD, Gretchen Haas, PhD, John Clarkin, PhD, Alfred
Lewis, MD
Presentation, "Predictors of Early Stabilization in Schizophrenia" as part of a Symposium, "Long-term
Treatment Issues in Schizophrenia" with Nina Schooler, PhD, Sam Keith, MD, Alan Balleck, MD, et al
The Annual Meeting of the Association for Clinical Psychosocial Research, Montreal, Canada, May, 1988:
Presentation, "Family Therapy Manuals: Treatment in Search of a Manual or Manuals in Search of a Treatment"
as part of a Symposium on Psychotherapy Manuals, with John Clarkin, PhD and Gretchen Haas, PhD.
The Annual Meeting of the American Family Therapy Association, Montreal, Canada, June, 1988:
Presentation, "Inpatient Family Intervention: Final Results for Schizophrenia and Affective Disorder"
Plenary Session, "NIMH Update"
The Regional Symposium of the World Psychiatric Association, Washington, D.C., October 1988:
Presentation: "Developing an Effective Treatment Equation"
Presentation: "The Family Model and Schizophrenia"
Participant on Panel: "Mental Health and the News Media," The Fourth Annual Rosalynn Carter Symposium on
Mental health Policy, Atlanta, October 1988.
Keynote Speaker, "National Priorities in Mental Health Research," First Annual Kansas Scientific Symposium,
Kansas City, October 1988.
Grand Rounds, "Family Therapy: Indications and Contraindications," Carrier Clinic, Princeton, NJ, 11/88.
Presentation: "The National Institute of Mental Health Public Academic Liaison Initiative," National Association of
Social Workers 1988 Annual Conference, Philadelphia, Pennsylvania, November 1988.
Presentation: "Fostering Collaborative Research that Impacts the Adminstration of Public Mental Health Programs:
The Federal Perspective." American Public Health Association, Boston, MA, November 1988.
The American College of Neuropharmacology (ACNP) 27th Annual Meeting, San Juan, Puerto Rico, 12/88:
Presentation of paper for the TSS Collaborative Study Group, "Depressive Symptomatology,
Negative Symptoms and Extrapyramidal Symptoms (EPS) in Acute Treatment Response and Short
Term Outcome," as part of a symposium, Acute Treatment Response and Short Term Outcome in
Schizophrenia"
Poster with the IFI Research Group, "Working with the Family to Improve Medication Compliance"
Keynote Remarks, "The NIMH Program for 1989 and its Implications for Training." Annual Meeting of AADRPT,
San Diego, California, January 1989.
40
40
Keynote Address, "NIMH Prospects and Promises," California Coalition for Mental Health, Los Angeles, California,
January 1989.
Presentation of paper, "The Programs of the NIMH and Their Implications for Training," 1989 Annual Meeting of
the Association for Academic Psychiatry, Atlanta, Georgia, March 1989.
Ground Rounds, "Among Doctors, Patients, and Family: Achieving Effective Treatment for Serious Mental Illness,"
Chope Hospital, San Mateo, California, April 1989.
Poster Presentation, "Depressive Symptomatology, Negative Symptoms and Extrapyramidal Symptoms (EMPS)
in Acute Treatment Response and Short Term Outcome," International Congress on Schizophrenia Research,
San Diego, California, April 1989.
At the Annual Meeting of the American Psychiatric Association, San Francisco, California, May 1989:
Workshop, Presentation of "The Family and DSM-IV: A Progress Report from the Group for the
Advancement of Psychiatry" (with LC Wynne MD, L Combrinck-Graham MD, and AL Price MD)
Workshop Chairperson, Presentation of "Public/Academic Liaison: Can It Work?" (with SC Shulz MD. JD
Burke MD, D Jones MSW, and GM Simpson MD)
Presentation, "Inpatient Family Intervention: Process Results" (with JF Clarkin PhD, JH Spencer MD, GL
Haas PhD, and AB Lewis MD) as part of a Paper Session, "Family Therapy Strategies"
Co-author, "Sex Differences in Schizophrenia Outcome," (with GL Haas PhD, JF Clarkin PhD, and
JH Spencer MD) as part of a Paper Session, "Schizophrenia Treatment Outcomes: New Consideration"
Co-author, "Social and Family Factors Predict Early Stabilization," (with NR Schooler PhD, JB Severe MS,
SJ Keith MD. AS Bellack MD, WA Hargreaves PhD, JM Kane MD, and PT Ninan MD) as part of a
Symposium, "Long-term Treatment Issues in Schizophrenia"
Presentation, "State/University Collaboration: The Public-Academic Liaison," National Conference on Mental
Health Statistics, San Diego, California, June 1989
At the Eleventh Annual Meeting of the American Family Therapy Association, Colorado Springs, CO, 6/89
Chair, Interest Group, "Medications, Hospitalization and Family Systems"
Presentation, "The Family and Treatment of Depression"
Presentation, "NIMH Update"
Grand Rounds, "Family Intervention for Affective Disorders," Dept. of Psychiatry, Louisiana State University
Medical Center, New Orleans, October 1989.
Invited Speaker, "The National Plan for Research to Improve Care of the Severely Mentally Ill," at a conference,
"Privatization of Mental Health Care: A National Perspective," Center for Health and Human Resources Policy,
JFK School of Government, Harvard University, Boston, Massachusetts, October 1989.
At the 1989 Institute on Hospital and Community Psychiatry of the American Psychiatric Association, Philadelphia,
October 1989:
Lecture, "Update from the NIMH"
41
41
Workshop, "Follow-up Studies of Hospitalized Psychiatric Patients: Triumphs, Tragedies, and
Surprises" (with Harding, CM)
Symposia, "Family Intervention and Psychiatric Hospitalization" (with Sholevar, GP)
Poster, "Improving Treatments for the Severely Mentally Ill - Implications of the Italian Psychiatric
Reform"
Grand Rounds, "The Effectiveness of Treatment for Major Depressive Disorder One year Later," Jefferson
Medical College, Philadelphia, November 1989.
Workshop, "Fundamentals of Mental Illness Research," National Mental Health Association Scientific Symposium,
Washington, November 1989.
At the 1990 Annual Meeting of the ACNP, Maui, December 1989.
Study Group, "Public/Academic Liaison to Generate Psychpharmacology Research: Can it Work?"
(Co-chair with Schulz S)
Open Session, "New Initiatives of the NIMH - the PAL Initiative"
Grand Rounds, "Working with the Family of the Hospitalized Patient: Is It Worth It Over the Long Run?" Holliswood
Hospital, Queens NY, December 1989.
Presentation of Paper, "A Cross National Followup Study of the Treatment of Major Depressive Disorder," Annual
Meeting Psychiatric Research Society, Park City, Utah, March 1990.
Grand Rounds, "Increasing the Effectiveness of Psychiatric Care: What Happens to Patients and Their Families
After Hospitalization", Dept. of Psychiatry, University of North Carolina, Chapel Hill, April 1990.
At the 1990 Annual Meeting of the American Psychiatric Association, New York, May 1990:
Vestermark Award Session, "Overview of the Model Curriculum and a Follow Up Evaluation of its
Usefulness," as part of the session, "The Teaching and Learning of Psychopharmacology in the 1990's:
How to Jump in a Rapidly Moving Train"
A Workshop, "National Plan Research on Severely Mentally Ill" (with Burke, J)
Presentation, "Cross-National Study of Major Depressive Disorders." as part of Symposium,
"Cultural Aspects of Depression in Asia and America"
Research Colloquia, "Drug and Family Treatment for Major Affective Disorder," Dept. of Psychiatry, University of
Pennsylvania School of Medicine, May 1990.
Brief Presentation, "Making Inpatient Family Intervention Work," American Family Therapy Association,
Philadelphia, June 1990.
Invited Presentation, "Implications of the Italian Reform for the Delivery of Mental Health Services in the U.S. and
Canada," sponsored by British Columbia Mental Health Society, Vancouver, July, 1990
At the 7th Annual Scientific Symposium, National Mental Health Association, "New Findings & Practical
Applications of Mental Health Research" Houston, Texas, 1990:
Workshop, "Fundamentals of Mental Illness Research"
42
42
Workshop, "Increasing the Effectiveness of Psychiatric Treatment."
Professional Symposium Series, "Psychoeducation for Patients and Families: What and How," Portsmouth
Pavilion, Portsmouth, New Hampshire, September, 1991.
Grand Rounds, "Effectiveness for the Patient and Their Families of Psychiatric Care: A Cross-National Study of
the Process of Treatment and Outcome of Major Depressive Disorder," Brookside Hospital, Nashua, New
Hampshire, September, 1991.
Grand Rounds: "The Family and Affective Disorder: A Followup Study." Butler Hospital, Brown University School
of Medicine, Providence, November 1990.
Grand Rounds: "Effectiveness of Inpatient Psychiatric Care: A Two Year Followup Study of Major Affective
Disorder." Manhattan Psychiatric Center, New York, December 1990.
Grand Rounds, "Does Treatment Help? The Process of Hospital Treatment and Outcomes for Major Depressive
Disorder." Dept. of Psychiatry, The New York Hospital-Cornell University Medical College, NY, 1/91.
Presentation, "A Model Curriculum in Psychopharmacology." Annual Meeting of the Association for Academic
Psychiatry, Free University Section, Tampa, Florida, March, 1991.
Grand Rounds, "Increasing Effectiveness of Psychiatric Care: What Happens to Patients and Their Families After
They Leave the Hospital." Dept. of Psychiatry, The New York Hospital-Cornell Medical College-Westchester
Division, NY, March 1991.
Grand Rounds,"The Changing American Couple and Indications for Marital Therapy." State University of New
York Health Science Center at Brooklyn, New York, April, 1991.
At the Annual Meeting of the American Psychiatric Association, New Orleans May 1991:
Presentation: "Family Outcome of Hospitalization for Mood Disorders" with Lorenzo Burti, MD,
Kuninao Minakawa, MD, Michael Sacks, MD, Katsua Maehara, MD
Invited Lecture: "The Integration of Psychopharmacology with Psychosocial Therapies for Treatment of
Psychoses" sponsored by The Bipolar Foundation, Buenos Aires, Argentina, July 1991.
Invited Lecture: "Psychoeducation as the Tool to Integrate Psychopharmacology with Psychosocial Therapies for
Schizophrenia and Bipolar Disorder." sponsored by The Uruguayian Psychiatric Society, Montevideo, Uruguay,
July 1991.
Invited Lecture: "Effectiveness in Psychiatric Care: A Followup Study of Major Affective Disorder." Dept. of
Psychiatry, LSU, New Orleans, October 1991.
Clinical Research Award Address: "Effectiveness in Psychiatric Care: II. Outcome for the Family After Hospital
Treatment for Major Affective Disorder." Annual Meeting of the American Academy of Clinical Psychiatrists, New
Orleans, October 1991.
At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 1991:
Study Group, "Maximizing the Effectiveness of Medication for Schizophrenia and Affective
Disorder," Study Group organizer and Co-chair as well as Presenter (with four others)
Presentation, "Effectiveness of Psychiatric Care, A Followup Study of Psychopharmacologic
Practices in Treatment of Major Affective Disorder." As part of a Symposium on Transcultural
Psychopharmacology organized by T. Ital and N. Sartorius
43
43
Poster, "Increasing the Effectiveness of Psychiatric Care: Achieving Effective Medication Management"
(with three others)
Grand Rounds, "The Changing American Couple and Indications for Marital Therapy." Coney Island
Hospital, Brooklyn, New York, January, 1992
At the Annual Meeting of the American Psychiatric Association, Washington, D.C., May 1992:
Debate: Resolved: For Most Psychiatric Inpatients, a Ten Day Hospitalization is as Effective as a Longer
Stay (with M. Herz, MD)
Paper: Increasing the Effectiveness of Treatment for Mood Disorder, as part of a symposium, The Family
and Mood Disorder.
New Research Poster: "Psychoeducation For Mood Disorder" with Lorenzo Burti, MD, Keigo
Okonogi, MD and Michael Sacks, MD.
Poster: "Achieving Effective Medication Management" with Lorenzo Burti, MD, Koji Suzuki, MD and Michael
Sacks, MD, NCDEU Annual Meeting, Boca Raton, Florida, June 1992.
International Seminar: "Revamping of the Uruguayan Mental Health System: New Patterns of Care, Methods of
Diagnosis and Treatment for Severe Mental Disorders" sponsored by the Uruguayan Psychiatric Association,
World Association for Psychosocial Rehabilitation and the Republican National Bank, Director and Lecturer,
Uruguay, June 1992 with John P. Docherty, MD.
Grand Rounds: "Alternative Treatments of Bipolar Disorder." Bronx State Psychiatric Center. NY9/92.
Grand Rounds: "Effectiveness in Psychiatric Care: A Follow-up Study of Hospitalized Patients with Major Affective
Disorder." St. Vincent's Hospital and Medical Center. New York. September, 1992.
Grand Rounds, "Alternative Treatments of Bipolar Disorder." Bronx State Psychiatric Center, NY,9/92.
Invited Plenary Lectures: At the Fall Meeting, Louisiana Psychiatric Association, Destin, Florida, 1992:
a) "Theoretical Background and Literature Underlying Psychopharmacotherapy and
Marital/Family Therapy Combinations"
b) "The New Algorithms for Combining Marital/Family Therapy with Drug and Other Psychotherapies"
Invited Lecture, "The Role of Psychotherapy in Combination with Pharmacotherapy," as part of a symposium,
"Bipolar Disorder: Current Progress and Future Directions in Diagnosis and Management," sponsored by Stanford
University School of Medicine, San Francisco, October, 1992.
Workshop, "The Millennium Has Arrived: Suggestions for a New Model of (and Research Questions about)
Hospital Treatment of Psychiatric Disorders," Institute on H&CP, Toronto, October, 1992.
Grand Rounds, "Combining Medication and Psychosocial Strategies for the Treatment of the Major Psychoses."
Stanford University Medical Center, Stanford, CA, November, 1992.
Grand Rounds, "Effectiveness in Psychiatric Care: What Happens to the Patient and Family After Hospitalization."
Creedmoor Psychiatric Center, New York, December, 1992.
44
44
At the Annual Meeting of the American College of Neuropharmacology (ACNP), Puerto Rico, December 1992:
Paper, Treatment Strategies in Schizophrenia, (with 12 co-authors)
Invited Lecture: "Combining Treatments to Improve Outcomes: A Follow up Study of Major Affective
Disorders in Italy, Japan and the United States." Bronx District Branch of the American Psychiatric
Association, New York, March, 1993.
At the Annual Meeting of the American Psychiatric Association, San Francisco, May, 1993:
Invited Speaker for the Annual Review of Psychiatry Series, the Combined Treatments Symposium,
Combining Medications with Family Psychotherapy (with Scott Goldsmith and John Clarkin)
Workshop, Medication and the Italian Reform (with L. Mosher, G. Palermo and A. Bartolomeis)
Lecture: "Increasing Effectiveness of Psychiatric Inpatient Care." Medical Staff, Dept. of Psychiatry, Stanford
University Hospital, September, 1993.
Grand Rounds, "Effectiveness in Psychiatric Care." Dept. of Psychiatry, Bronx-Lebanon Hospital Center, Bronx,
NY, November 1993.
At the Annual Meeting of the American College of Neuropharmacology (ACNP), Hawaii, December 1993: Paper, Promising New Medications for Schizophrenia not Available in the U.S.A., (with five co-authors) as part of the European College of Neuropsychopharmacology panel, Are You Missing Anything? Recent Psychotropics Available in Europe, But Not in U.S.A. (Chair, Stuart Montgomery) Poster, Promising Psychopharmacologic Medications not Available in the U.S.A. (with five co-authors)
Lecture: "Medication Combined With Couples Treatment" as part of a symposium, "Clinical Pharmacology: An
Update", Stanford University School of Medicine, January, 1994.
Grand Rounds: “The Role of the Psychiatric Hospital in the 1990’s,” Langley Porter Psychiatric Institute, UCSF,
San Francisco, March 1994.
Grand Rounds: “New Strategies for the Treatment of Acute and Chronic Schizophrenic.” California Medical
Facility, Vacaville, CA. April 1994.
Grand Rounds: “Atypical Antipsychotic Medications,” Sacred Heart General Hospital, Eugene OR, April 1994
Invited Presentation: “A Cross Cultural Study of Treatment of Mood Disorders in Italy, Japan and the United
States,” The Northern California Psychiatric Society 1994 Annual Meeting, Olympic Valley, CA, April, 1994.
Lecture: “New Strategies for Treatment of Acute and Chronic Schizophrenia” as part of a symposium, New
Approaches to Treating Schizophrenia. Stanford University School of Medicine, May 1994.
Paper: Psychiatric Aspects of Basketball Annual Meeting, International Society of Sports Psychiatry, Philadelphia,
May 1994. Poster: Efficacious and Safe Psychotropics Not Available in the US., 1994 Annual Meeting, Society of Biological Psychiatry, Philadelphia, May 1994. Training Seminar: The Legal - Psychiatric Interface, for San Francisco, Santa Clara & San Mateo judges and other legal mental health professionals, San Jose, CA, August, 1994.
45
45
Keynote Address, "Combining Medication with Psychosocial and Rehabilitation Strategies in the '90s": sponsored by
the Department of Psychiatry, University of Saskatchewan and the Department of Psychiatry, University of Alberta
Hospitals, presented at Edmonton, Saskatchewan, and at Kingston,Canada, October, 1994.
Grand Rounds, "Combining Medications and Psychotherapy in the 1990's: Researching Clinical Issues". California
Pacific Medical Center, San Francisco, October, 1994.
Grand Rounds, "Changing Models of Psychiatric Care: Psychiatric Hospitalization for the 90's." Chope Hospital &
San Mateo Health Services Agency, San Mateo, CA, November, 1994.
Poster: "Current European Clinical Trials of Anti-Dementia Drugs," (with Shwartz GE, Montgomery S, Klein F) at
the 1994 Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico,
December, 1994.
Grand Rounds, "Combining Psychotherapy and Drugs in the 1990's." Department of Psychiatry, University of
Arizona Health Sciences Center, Tucson, January, 1995.
Lecture: "Combining Psychotherapy & Pharmacotherapy" as part of the 1995 Annual Meeting of the American
College of Psychiatrists, Acapulco, Mexico, February, 1995.
Grand Rounds, "Diagnosis and Treatment of Psychotic Disorders Related to Parturition" Department of Ob/Gyn,
Stanford University School of Medicine, March, 1995.
At the Biannual International Congress on Schizophrenia Research (ICSR), Warm Springs, VA, May, 1995
Poster: Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic
Outpatients, (withSchultz SC, TSS Collaborative Study Group). Poster: Promising Psychopharmacologic Medications Not Available in the USA, Glick, ID, (with Lecrubier Y, Montgomery S, Vinar O, Klein DF). Clinical Update: "The Forces Forming Character," at the 1995 Annual Meeting of the Northern California Psychiatric Society,Pacific Grove, CA, April,1995.
Keynote: "Combining Family Therapy with Medication for the Treatment of Axis I Disorders." as part of seminar, Effective Approaches: Working With Children, Adolescents and Their Families. Tender Lion Family Program, Family Service Agency of San Francisco, April 1995. Grand Rounds: "New Strategies for Treating Schizophrenia," Eden Hospital, Castro Valley, CA, May, 1995.
Poster: "New Psychopharmacologic Strategies for Treatment," (with Braff D, Janowsky D) at the 1995 Annual Meeting of the Society for Biological Psychiatry, Miami, FL, May, 1995. Grand Rounds: "The Effectiveness of Family Therapy for Inpatient Psychiatric Patients,” Department of Psychiatry, School of Medicine, UC Davis, and Sacramento County Mental Health, Sacramento, November, 1995. Grand Rounds: "Psychiatric Hospitalization for the 90's," Napa State Hospital, Napa, CA, December,1995. At the Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Puerto Rico, December 1995. Mentor: Travel Awardee. Poster: New Treatment Strategies, (with Braff D, Janowsky D). Poster: Treatment Outcomes of First Episode & Chronic Multiepisode Schizophrenia, (with Lieberman J, et al). Study Group: A Psychopharmacologic Jam Session: A Dialogue on Tricks of the Trade, (with Janowsky D, Klein D, Schatzberg A)
46
46
Lecture: "Family Therapies: Efficacy, Indications and Therapy Outcomes." Annual Meeting of the American Psychopathological Association, New York, March, 1996. Lecture: "Pharmacologic Treatment of Schizophrenia,” at the 1st Stanford Review of Psychopharmacology Course, San Francisco, March, 1996. Grand Rounds: “A Model Curriculum in Psychopharmcology for the 21st Century,” San Mateo County General Hospital, San Mateo, March, 1996. Grand Rounds: “Sertindole and New Antipsychotic Therapies for Schizophrenia,” Atascadero State Hospital, Atascadero, CA, April, 1996. Grand Rounds: “New Treatments and New Pharmacologic Strategies for Schizophrenia,” Sutter Center for Psychiatry, Sacramento, CA, April, 1996. Lecture: “Advancing the Treatment of Mania.” Departments of Psychiatry, University of California, Irvine and University of Southern California, Los Angeles, CA, June, 1996. At the Annual Meeting of the American Family Therapy Academy, San Francisco, June 1996. Poster: “Inpatient Family Intervention: Final Results from a Controlled, Random-Assignment Study,” (with three others). Roundtable: “The Family Model and Psychiatric Illness.” Grand Rounds: “Combing Medication with Family Intervention for Axis I Disorders,” Hackensack Hospital Medical Center, Hackensack, NJ, September, 1996. International Congress: Schizophrenia: New Frontiers, Association for Research on Schizophrenia, Milan, October, 1996. Keynote: “Family Associations and Family Therapy: From Conflict to Collaboration.” Workshop: “Psychoeducational Treatment of Schizophrenia: The Inpatient Family Intervention Study Experience” Grand Rounds: “Treatment Strategies in Schizophrenia: Final Results,” Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Stanford, CA, November, 1996. Grand Rounds: “New Drugs and New Strategies in Schizophrenia,” Menlo Park Veterans Administration Hospital and Palo Alto Veterans Administration Hospital, Menlo Park and Palo Alto, CA, November, 1996. Grand Rounds: “Combining Medication with Psychotherapeutic Intervention, “ Dept of Psychiatry, University of Miami School of Medicine, Miami, December, 1996. Grand Rounds: “Atypical Antipsychotics & New Treatments/New Strategies for Schizophrenia” • Kaiser Hospital, San Francisco, CA, November, 1996 • Central Missouri Psychiatric Society, St. Louis, MO, November, 1996 • Boone County Medical Society, MO, November, 1996 • Fulton State Hospital, Fulton, MO, November, 1996. • Coutesville V-A Medical Center, Coutesville, PA, December, 1996 • Institute of Pennsylvania, Philadelphia, PA, December, 1996 • Arizona Alliance for the Mentally Ill, Phoenix, AZ, January, 1997 • Good Samaritan Regional Medical Center, Phoenix, AZ, January, 1997 • Porter Hospital, Denver, CO, January, 1997 • University of Colorado Health Sciences Center, Denver, CO, January, 1997 • First Hospital, Vallejo, CA, February, 1997 • Mercy Memorial Hospital, Ardmore, OK, March, 1997 • St Mary’s Hospital, Colorado West Mental Health Meeting, Grand Junction, CO, April, 1997 • Lakeview Veterans Administration Hospital, Chicago, IL, June, 1997 • California Psychiatric Society South Coast Chapter, Santa Cruz, CA, July, 1997 • County of Santa Cruz Community Mental Health Services, Santa Cruz, CA, July, 1997 • Fulton State Hospital, Fulton, MO, August, 1997 • Department of Psychiatry, School of Medicine, University of Missouri, Columbia, MO, August, 1997
47
47
• Flower Hospital, Toledo, OH, September, 1997. • International Health Care, Salt Lake City, UT, September, 1997. • Napa State Hospital, Napa, CA , 1997. • Sacred Heart Medical Center, Spokane, WA, October, 1997. • John George Psychiatric Pavilion, San Leandro, CA, November, 1997. • Tampa General Hospital, Tampa, FL, February, 1998. • Florida Hospital, Orlando, FL, February, 1998. • Peninsula Hospital, Burlingame, CA, January, 1999. At the Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Puerto Rico, December, 1996. • Study Group: “A Psychopharmacologic Jam Session:Tricks of the Trade,” moderator and participant. • Poster: “New Psychotropic Drugs for Axis I Disorders: Recently Arrived, In Development, and Never Arrived” (with Belanoff J, Golden W). Grand Rounds: “Inpatient Family Intervention: A Controlled Study,” National University of Taiwan, Taipai, Taiwan, December, 1996. Grand Rounds: “Combining Medication with Family Intervention for Axis I Disorders,” Texas Tech Health Sciences Center, Amarillo, TX, January , 1997. Medical Students’ Forum: “Working With Families of Seriously Ill Patients,” Texas Tech Health Sciences Center, Amarillo, TX, January, 1997. Grand Rounds: “Combined Therapy for Treatment of Axis I Disorders,” First Hospital Vallejo, Vallejo, CA, February, 1997. Research Seminar: “Treatment Strategies in Schizophrenia: Final Results,” Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, IA, March, 1997. Grand Rounds: “Combining Medicine in Psychosocial Intervention,” Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, IA, March, 1997. Keynote: “New Developments in Antipsychotics,” Western Colorado Psychiatric Meeting, Colorado Springs, CO, April, 1997. International Congress on Schizophrenia Research, Colorado Springs, CO, April 1997. Poster: New Psychotropic Drugs for Schizophrenia (with Belanoff J). Grand Rounds: “Diagnosis and Treatment of Schizophrenia,” St. Vincents Hospital, New York, NY, April 1997. Invited Seminar: “New Treatments for Agitation and Aggression in Axis I Disorders,” University of Medicine and Dentistry of New Jersey, Piscataway, NJ, April, 1997. Lecture: “Current Concepts in the Treatment of Schizophrenia,” Conference: Understanding and Treating Schizophrenia: Progressing into the Next Century, Ann Arbor, MI, April, 1997. At the Annual Meeting of the American Psychiatric Association, San Diego, CA, May, 1997: Paper: “New Strategies and New Treatments for Schizophrenia,” (with Belanoff J and DeBattista C). Paper: “The Professional Athlete as Role Model.” Poster: “The Teaching of Psychopharmacology in the 1990’s,” (with Klein D, Doraiswamy M, Lydiard B). NCDEU Annual Meeting, Boca Raton, FL, June, 1997. Lecture: “Combining New Antipsychotics with Psychosocial Intervention in the 1990’s,” St. Lawrence Hospital, E. Lansing, MI, September, 1997. Lecture: “Combining New Antipsychotics with Psychosocial Intervention in the 1990’s,” as part of the program, Contemporary Issues in Psychiatry. Huran Valley Center, Yipsilanti, MI, September, 1997.
48
48
Lecture: “New Treatment Approaches for Psychosis in the Elderly,” McComb Hospital, Detroit, September, 1997. Grand Rounds: “New Treatments for Schizophrenia,” Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, October, 1997. Grand Rounds: “New Treatments for Schizophrenia,”Department of Psychiatry, School of Medicine, Indiana University, Indianapolis, IN, November, 1997. At the 36th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Waikoloa, HI, December, 1997. Poster: “The Teaching of Psychopharmacology in the 1990’s,” (with ASCP Committee)). Poster: “Extrapyramidal Symptom Profile of Sertindole,” (with L. Ramirez) Continuing Education Update on Schizophrenia, for Neuroscience Regional Research Managers, Eli Lilly Co., at Stanford University School of Medicine, February, 1998. Expert Breakout Session (Schizophrenia). Second Stanford Psychopharmacology Review Course. Stanford, CA, March, 1998. Lecture: “New Treatments and New Strategies for Schizophrenia: New Data,” West Coast College of Biological Psychiatry, Palo Alto, California, 1998. Lecture: “Progress in Psychoses: Improving Treatment and Evaluation, Enhancing Cognition,” Continuing Medical Education Seminar, Los Angeles, April, 1998. Grand Rounds: “Combining Medication with Psychotherapy,” Weber County Mental Health Center, Ogden, Utah, April, 1998. Grand Rounds: “New Treatments and New Strategies for Schizophrenia,” University of California at Irvine, Irvine, California, April 1998. Grand Rounds: “New Treatments and New Strategies for Schizophrenia,” Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, May 1998. Grand Rounds: “Combining Medication and Psychotherapy for Psychiatric Disorder,” North Shore University Hospital, Great Neck, New York, May 1998. Grand Rounds: “Combining Medication with Psychotherapy,” Department of Psychiatry, Wright State University School of Medicine, Dayton, Ohio, May, 1998. Grand Rounds: “The Patient, the Family and Medication,” Palo Alto and Menlo Park Veterans Administration, California, June , 1998. At the Annual Meeting of the American Psychiatric Association, Toronto, May, 1998: Industry Symposium: “ New Atypical Antipsychotics: Data versus Clinical Experience,” Chair and lecturer: Lecture 1: “History of Somatic Therapy for Schizophrenia” Lecture 2: “Combining Medication with New Antipsychotics” Grand Rounds: “An Overlooked Serotonin Dopamine Blocker; Loxapine Revisited,” Atascadero Forensic Center, Atascadero, California, September, 1998. Grand Rounds: “New Atypical Antipsychotics,” Department of Psychiatry, Louisiana State University, New Orleans, October, 1998. Lecture: “Schizophrenia: Receptor Profiles & Efficacy,” at the Continuing Education Seminar, Psychopharmacology 1998 Clinical and Research Update, sponsored by Department of Psychiatry, Stanford University and West Coast College of Biological Psychiatry, San Francisco, California, October , 1998.
49
49
Invited Lecturer: “Clinical Efficacy of Antipsychotics,” at the World Psychiatric Association and the Mexican Psychiatric Association, Guadalajara, Jalisco, Mexico, October, 1998. Invited Lecturer: “Combining Medication Therapy with Family Interventions,” Bipolar Disorder Mini fellowship, Stanford University School of Medicine, Palo Alto, California, November,1998 Grand Rounds: “Combining Medication with New Antipsychotics,” Herrick Hospital, Berkeley, California, November, 1998. Invited Lecturer: “A Model Curriculum in Psychopharmacology,” Payne Whitney Clinic and Cornell University Medical College, New York, December, 1998. At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December, 1998: Study Group: A Psychopharmacological Jam Session: A Dialogue on Psychosis, (Moderator and Participant) Poster: “New Psychotropic Drugs for Axis I Disorders; Recently Arrived, in Development and Never Arrived,” (with JK Belanoff and JS Ballon). Poster: “The Teaching of Psychopharmacology in the 1990’s: The First Year Experience with the Model Curriculum,” (with PM Doraiswamy, J Halper, DS Janowsky, DF Klein, RB Lydiard, J Osterheld, DW Preven, P Ross, NG Ward and S Zisook). Grand Rounds: “Combining Medication and Psychotherapy for Axis I Disorders,” Dept Psychiatry, College of Physicians and Surgeons and New York State Psychiatric Institute, New York, December, 1998. Grand Rounds: “Combining Medications with Psychosocial Intervention for Axis I Disorders,” Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, January,1999. Grand Rounds: “Combining Medications with Psychosocial Intervention for Axis I Disorders,” Department of Psychiatry, University of Texas at Houston, March, 1999. Symposium: “ Teaching Biological Psychiatry to Residents, West Coast College of Biological Psychiatry, Tucson, April, 1999. At the Biannual International Congress on Schizophrenia Research, Santa Fe, April, 1999: Poster: “The Efficacy Spectrum for New Antipsychotics in Clinical Practice with S Marder, P Vasudevan. Poster: “Comparisons of the Effects of the Newer Atypical Antipsychotics in the Treatment of Schizophrenia,” with J Davis. Grand Rounds: “Combining Drugs and Ps;ychotherapy for Axis I Disorders.” Department of Psychiatry, University of Mississippi Medical Center, Jackson, May, 1999. At the Annual Meeting of the American Psychiatric Association, Washington DC, May, 1999: Paper Presentaton: “A Model Psychopharmacology Curriculum (with DF Klein and B Lydiard, et al) Paper Presentation: “Keeping the Athlete Functioning,” (with J Horsfall). Invited Lectures: “The New Atypical Antipsychotics - Efficacy and Outcomes,” delivered in May, 1999 at
Departments of Psychiatry in Japan at: • St Marianna University, Tokyo • Hiroshima University, Hiroshima • Kyorin University, Tokyo • Fukushima Medical University (joint sponsorship with the Fukushima Medical Society), Fukushima Invited Lecture: “Psychopharmacology in Psychiatry.” Department of Psychiatry, University Hospital Utrecht, The
Netherlands, August 1999. Grand Rounds: “New Treatments for Psychoses.” The Netherlands, August, 1999. •Vincent van Gogh Hospital, Venray • Delta Hospital, Portugal Workshop: Annual Meeting of the Association for Academic Psychiatry, New Orleans, October, 1999.
50
50
• A Follow up Evaluation of a Model Curriculum in Psychopharmacology, 1999 Workshops: Northwest Medical Health Institute and Oregon Psychiatric Association, Gleneden Beach, Oregon,
November, 1999. • New Treatments for Psychosis in the Year 2000 • Combining Medication with Psychotherapy for Axis I Disorders Grand Rounds: “Combining Medication with Psychotherapy for Axis I Disorders.” Santa Barbara County CMHC,
Santa Barbara, November, 1999. Grand Rounds: “New Short and Long-term Strategies for Schizophrenia, Bipolar Disorder and Depressive
Disorder.” Department of Medicine, Stanford University School of Medicine, December, 1999. Grand Rounds: “Teaching Psychopharmacology in the New Millennium.” Department of Psychiatry, University of
Hawaii at Manoa, December, 1999. Study Group Presentation: “Clozapine Treatment Resistance: What Does it Mean? New Methodological Issues in
the Study of Treatment Refractory Schizophrenia,” at the Annual Meeting of the ACNP, Acapulco, Mexico, December, 1999.
Invited Lecture: “New Treatments and New Strategies for Psychosis for the Millennium,” 2000 Annual Meeting of
the Philippine Psychiatric Association, IIilo, Philippines, January, 2000. Grand Rounds: “Combining Medical and Psychosocial Interventions for Schizophrenia.” Grand Rounds
Presentation at Nihon University and Keio University, Tokyo, Japan, February, 2000. Workshop: Organizer and Moderator, “Introduction to Neuropsychopharmacology: Pathophysiology to Clinical
Practice.” A Workshop for the Neurobiology Unit, Roche Bioscience. Palo Alto, CA, February, 2000. Lectures: • Overview of New Medication Strategies for Axis I Disorders • Schizophrenia • Clinical Trials Design (with Alan Schatzberg) Invited Lecture: “Long Term Maintenance: Risperidol versus Haldol.” In the symposium, “Psychosis: New
Perspectives and Strategies,” Monte Carlo, March, 2000. Korea: April, 2000
• Grand Rounds: “Indications for New Antipsychotics,” Seoul National University, Seoul.
• Invited Lecture: “New Treatments for Bipolar Disorders,” Annual Meeting, Korean Psychopharmacology
Association.
• “New Antipsychotics for Bipolar Disorder,” Samsung Hospital, Seoul.
• Regional Symposium, Kyong-Ju, “New Antipsychotics for Bipolar Disorder.”
• Regional Symposium, Kwang-Ju, “New Antipsychotics for Bipolar Disorder.”
At the 2000 Annual Meeting of the American Psychiatric Association, Chicago, May, 2000. • Industry-supported Symposium: New Antipsychotics: From Practice to Theory. - Co-chair and Paper, “The Efficacy Spectrum for Atypicals in Clinical Practice.” • Symposium: Psychopharmacological Approaches to the Athletic and Exercise Population. - Paper, “Diagnosis and Psychiatric Treatment of Athletes.” • Media Session: - Cultural Identity on the Tex Mex Border: Impact on Relationships Past and Present, discussion of movie, Lone Star, Chair and Presenter Co-Chair, Forum, “The Future of Psychopharmacology: Generativity and Mentoring” at the NCDEU Annual
Meeting, Boca Raton, May, 2000. Grand Rounds: “Combining Medication with Psychotherapeutic Intervention for Axis I Disorders.” Department of
Psychiatry, University of California at San Diego, June, 2000. Grand Rounds: “Atypical Antipsychotics.” Alameda Center for Behavioral Healthcare, June, 2000.
51
51
Sabbatical, New Zealand and Australia, July-August, 2000
New Zealand
Grand Rounds, “New Treatments for Psychosis,” Dept Psychiatry, School of Medicine, Otago University,
Dunedin, July, 2000.
Australia (August, 2000)
All “grand rounds” presentations or as “invited lecturer” for community mental health practitioners and
students on 1) atypical antipsychotics, 2) combining medication with psychotherapy and/or 3) the teaching
and learning of pharmacotherapy.
Brisbane
• Royal Brisbane Hospital
• Princess Alexandra Hospital
• Prince Charles Hospital
• Ipswich Hospital and Wolsten Park Hospital
Sydney
• Royal North Shore Hospital
• Macquarie Hospital
• Hornsby Hospital and Manley Hospital
• Cumberland Hospital
• Nepean Hospital
• St. Vincents Hospital
Melbourne
• Royal Melbourne Hospital
• St. Vincents Hospital
• Alford Hospital
• Teleconference: Hallarat, Bendigo, Hobart, Warrnambool and Trarigan Hospitals
• EPPIC Mental Health SKY Unit
• Round Table with Professors of Psychiatry, Victoria
• Plenary Lecture: New Trends in Treating Psychosis regional symposium
Adelaide
• Royal Adelaide Hospital, Glenside Campus
• Lecture, Southern Australian Psychiatrists
Perth
• Graylands Hospital
• Lectures, Psychiatrists both Southern and Northern regions
• Queen Elizabeth Hospital
Grand Rounds: “New Drugs for Brain Disorders.” Department of Pharmacology and Toxicology, College of
Pharmacy, University of Texas, Austin, September 2000. Grand Rounds: “Combining Medication and Psychotherapy.” Department of Psychiatry, University of Texas, San
Antonio, September 2000. Invited Speaker: “New Drugs for the Treatment of Psychoses.” Central California Psychiatric Society, Fresno,
September 2000.
Workshop: “The Nuts and Bolts of Psychiatric Course Planning in the New Millennium.” 2000 Annual Meeting of
the Association of Academic Psychiatry, Vancouver, October, 2000 (with Rona Hu).
Grand Rounds: “The New Atypical Antipsychotics.” Western State Psychiatric Hospital, Seattle, November, 2000.
Invited Lecturers: US Psychiatric and Mental Health Congress, San Diego, November 2000
• “Combining Medication and Psychotherapeutic Intervention”
• “Diagnosis and Psychiatric Treatment of the Elite Athlete”
52
52
Grand Rounds: “Cutting Edge Inpatient Pharmacotherapy.” San Mateo Community Mental Health Service. San
Mateo, November 2000.
Postgraduate Education Seminar, for Lilly Pharmaceutical Co. (Japan). “Treatment of Psychosis in the New
Millennium,” Dec. 2000.
At the 2000 Annual Meeting of the ACNP, Puerto Rico, December, 2000
• Study Group: Comparing Antipsychotics: What Do We Really Know? Chair and Presenter; (with Rajiv
Tandon, Moderator).
• Poster, A Model Psychopharmacology Curriculum (with the ASCP Committee)
• Poster, The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics (with J. Davis).
Grand Rounds: “New Antipsychotics – Controversies and Questions.” Palo Alto Veterans Administration, Palo Alto, January 2001.
Invited Lecture: “Psychosis and Atypical Antipsychotics,” at the conference “Psychopharmacology in the Year
2001,” sponsored by the American Society of Clinical Psychopharmacology, Maui, February 2001.
Grand Rounds: “New Treatments for Psychosis.” Maui Community Mental Health Center, Maui, February 2001.
Preceptor: “Update on Schizophrenia.” Pfizer Preceptorship, Stanford, CA, February 2001.
Invited Lectures: Japan, March 2001
• “Combining Medication with Psychosocial Intervention for Treatment of Schizophrenia,” at 1) Department
of Psychiatry for School of Medicine, Hiroshima University, 2) at Kita-Kyusyu University, Kyushu, and 3) at
the National Center of Neurology and Psychiatry (NCNP), Tokyo.
• “Atypical Antipsychotics,” for the Department of Psychiatry, School of Medicine, Chiba University, Chiba.
Grand Rounds: “Long-term Treatment of Schizophrenia in the Community.” Santa Maria County Mental Health
Center, Santa Maria, CA, April 2001.
Lecture: “Treatment of Geriatric Psychosis.” St Johns Medical Center, Oxnard, CA, April 2001.
Grand Rounds: “Atypical Antipsychotics.” Santa Barbara College Hospital, Santa Barbara, CA, April 2001.
Invited Lecture: “Diagnosis and Management of Treatment-Resistant Schizophrenia,” at the symposium,
“Psychiatric Care in Community Residential Setting,” sponsored by the Los Angeles County of Mental Health and the Southern California Psychiatric Society, Los Angeles, CA, April 2001.
At the 2001 Annual Meeting of the American Psychiatric Association, New Orleans, May, 2001.
• Chair, Industry Symposium, A New Era for Managing Psychosis: Rebuilding Lives for Patients and
Families.
Paper, “Consumer Organizations May Improve Medication Compliance.”
• Poster, “The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics,” with Davis, J.
• Poster, “Ziprasidone’s Benefits Versus Olanzapine on Weight and Insulin Resistance.”
• Presentation, A Model Curriculum in Psychopharmacology, at the workshop, “Teaching
Psychopharmacology to Residents Using Evidence-based Algorithms.”
NCDEU 2001 Annual Meeting, Phoenix, May, 2001
• Poster, “The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics.”
• Co-Chair, Workshop, “Mentoring Throughout the Professional Life Cycle: Challenges and Lessons”
(with A. Gelenberg)
7th World Congress of Biological Psychiatry, Berlin, Germany, July 2001
• Poster, “Ziprasidone vs Olanzapine: Weight, Lipids, Insulin.”
53
53
Grand Rounds: “New Antipsychotics: Ziprasidone.” Kaiser, Santa Teresa, San Jose, August 2001.
CME Lecture: “Schizophrenia: New Treatment Dimensions,” at the program, “Psychopharmacology Clinical and
Research Update,” sponsored by the West Coast College of Biological Psychiatry, San Francisco, CA,
October 2001.
Grand Rounds: “New Antipsychotics: Current Controversies.” Menlo Park Veteran’s Administration Hospital,
Menlo Park, December, 2001.
At the 2001 Annual Meeting of the American College of Neuropsychopharmacology, Hawaii, December 2001.
• Chair, Special session, “Teaching Neuropsychopharmacology,” and presentation, “The Teaching of
Psychopharmaclogy: Who Does It? With What Materials?)
• Poster, “Improving the Teaching of Psychopharmacology: Circa 2001,” (with D Janowsky and S Zisook).
• Poster, “The Efficacy of Atypical Antipsychotics Compared to Typical Antipsychotics: A Meta-Analysis
Revisited,” (with N Chen and J Davis).
Lectures: “Current Controversies Around the New Atypical Antipsychotics,” at the Nevada Adult Mental Health
Center, and the Psychiatry Dept, Nevada Dept of Corrections, Reno, Nevada, Dec. 2001.
Grand Rounds: “Advancements in the Management of Schizophrenia.” Spokane Community Mental Health
Center, January, 2002.
Grand Rounds: “Schizophrenia: The New Atypical Antipsychotics.” Dept of Psychiatry, Oregon Health Sciences
University, Portland, Oregon, January, 2002.
Grand Rounds: “New Data and New Indications for the Atypical Antipsychotics in Both Psychotic and Non-
psychotic Disorders.” Department of Psychiatry and Behavioral Sciences, Stanford University School of
Medicine, Stanford, CA, March, 2002.
Invited Lecture: “The Use of New Antipsychotic Agents to Treat Bipolar Disorder,” as part of a CME course on
treating BIpolar Disorder. Department of Psychiatry, UC Davis, Sacramento, CA, March, 2002.
Grand Rounds: “Clinical Management of Psychosis: The Short- and the Long-term.” UCLA Neuropsychiatric
Institute, Los Angeles, CA, April, 2002.
Grand Rounds: “Fiscal Pharmacology of the Atypical Antipsychotics.” Napa State Hospital, Napa CA, April,
2002.
CME Lecture: “Stabilizing the Dopamine-Serotonin System: A New Era in the Treatment of Psychosis.” San
Diego, CA June, 2002.
Grand Rounds: “The Efficacy of Atypical Antipsychotics: A Meta-analysis Revisited.” Manhattan State
Hospital, New York, New York, June 2002.
Sabbatical, Japan, July 2002
Plenary Lectures: “The New Atypicals: New Data and Controversies” at the symposium “Challenges and
Opportunities in the Management of Schizophrenia, “Osaka and Tokyo, July, 2002.
Grand Rounds: “The New Atypicals: Challenges and Opportunities,” 1) Kyoto University, 2) Sapporo
Medical School, 3) Tokushima Medical School and 4) Okayama International Hospital.
CME Lecture: “Borderline Personality Disorder, Medication and the Family.” Conference, on Borderline
Personality Disorder, Research and Treatment, Stanford University Medical Center, September, 2002.
54
54
Grand Rounds: “The New Atypicals.” Northwest Behavioral Healthcare, Department of Mental Health,
Northfield, Ohio, September, 2002.
CME Lecture: “Novel Antipsychotics: What We’ve Learned; What We Need to Know.” Case Western Reserve
University School of Medicine, Cleveland, September, 2002.
CME Lecture: “New Steps in the Evolution of Antipsychotics: The Role of Partial Agonists,” Sponsored by
Bristol-Myers Squibb and Otsuka Pharmaceutical:
San Diego, June, 2002; San Francisco, September, 2002; New York City, September, 2002;
Seattle, March, 2003; Phoenix, April, 2003; Long Island, May, 2003.
Grand Rounds: “The New Atypicals.” Metropolitan State Hospital, Los Angeles, Sept 2002.
Grand Rounds: “The New Atypicals.” San Joaquin Community Mental Health Center, Fresno, September
2002.
Lecture: “Mental Illness and the Workplace.” Section on Labor Law, Annual Meeting of the State Bar of
California, Monterey, October 2002.
Grand Rounds: “The New Atypicals.” San Francisco Veterans Administration Hospital, San Francisco,
October 2002.
Grand Rounds: “Update on the Atypical Antipsychotics.” Department of Psychiatry, University of California at
San Diego, San Diego, October 2002.
Grand Rounds: “Aripiprazole and the New Antipsychotics.” Mood Disorders Program, UCSF, San Francisco,
November 2002.
CME Lecture: “The New Antipsychotics: Are There Differences?” First West Coast ASCP
Psychopharmacology Symposium, San Francisco, November, 2002.
Lecture: “Aripiprazole Efficacy and Safety.” Continuing Education Meeting, BMS, Laguna Nigel, CA
November 2002.
Grand Rounds: “Second Generation Antipsychotics: New Data and New Dilemmas.” Napa State Hospital,
Napa, CA, December 2002.
At the 2002 Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December
2002:
• Chair, Second Annual Session on “Teaching Neuropsychopharmacology,” and presentation of paper
“The ASCP Model Psychopharmacology Currticulum: New Scope and New Audiences.”
• Poster: “Cocomitant Psychotropic Medication Use in a Two-Year Study Comparing Clozapine and
Olanzapine for the Prevention of Suicidal Behavior.”
• Poster: “A Meta-analysis of the Efficacy of Second-Generation Antipsychotics,” (with John Davis)
National Teleconference: “Improving Outcome in Schizophrenia.” Psychlink, Dallas, TX, January 2003.
Grand Rounds: “Update on Mood Disorders.” Carlisle Hospital, Carlisle, PA, January 2003.
Public Lecture: “The Changing American Family: New Roles, Opportunities and Challenges for Men, Women
and Children.”
Dickinson College, Carlisle, PA, January 2003.
Lecture: “The New Atypicals and Treatment of Psychoses at the 2003 Biannual CME Conference.” University
of Wisconsin School of Medicine and Madison Institute of Medicine, Madison, WI, March 2003.
55
55
Plenary Lectures: Annual Meeting Central California Psychiatric Society, Monterey, CA , March 2003.
• “Combined Treatment of Axis I Disorders”
• “The New Atypicals”
Invited Lecture: “Recent Advances in Treatment of Schizophrenia.” Stanford University School of Medicine
Seventh Psychopharmacology Course, Update in Psychopharmacology Clinical Case Conference,
Stanford, March, 2003.
Poster: “The Efficacy of Atypical Antipscychotics Compared to Typical Antipscychotics: A Meta-Analysis.” (with
N Chen and J Davis). International Congress of Schizophrenia Research, Colorado Springs, CO April,
2003.
Presentation: “Effectiveness of Aripiprazole.” Regional Advisory Council – Bristol Myers-Squibb, Phoenix, AZ,
April, 2003.
Grand Rounds: “New Atypicals: New Medications and New Controversies.”
LSUHSC, Shreveport, LA
Baton Rouge CMHC, Baton Rouge, LA, April 2003
Grand Rounds: “Atypicals: New Drugs – New Controversies.” St. Peter Regional Treatment Center, St. Peter,
MN, May 2003.
Invited Lecture: “Combining Medication with Psychotherapy.”
St. Luke’s Hospital, Dept of Psychiatry, Racine, WI
Rogers Memorial Hospital, Dept of Psychiatry, Milwaukee, MN, May 2003.
At the 2003 Annual Meeting of the American Psychiatric Association, San Francisco, May, 2003.
• Lecture, “Clinical Considerations in the Management of First-Episode and Acute Exacerbation of
Schizophrenia,” as part of the industry-supported symposium, Managing the Spectrum of Psychotic
Disorders.
• Discussion, as part of an Issue Workshop: Psychiatric Perspectives on the Execution Process: A
Continuing Conundrum, with HJ Osofsky, RK Bailey, AM Freedman, AL Halpern, DM Mancuso
• Lecture: “Overview of the Efficacy of 2nd and 1st Generation Antipsychotics,” as part of an APA
symposium , Meta-Analyses of the Efficacy of 2nd vs 1st-Generation Antipsychotics, chaired by ID Glick
and JM Davis.
• Discussion, Efficacy of Atypicals in Acute Care Settings, as part of an industry-supported symposium,
Best Practices in Antipsychotic Use.
Plenary Speaker: “Update on Care and Treatment of Schizophrenia.“Southeast Regional Committee, National
Alliance for the Mentally Ill, Pennsylvania Chapter. Norristown State Hospital, Norristown, PA, June
2003.
Grand Rounds: “Atypicals: New Drugs and New Controversies,” June 2003.
• Milwaukee Veterans Administration
• Milwaukee County Mental Health Clinic
• Winnebago Mental Health Clinic
Colloquium: “Recent Trends in the Development of Novel Antipsychotics.” Atascadero State Hospital, CA, July
2003.
Grand Rounds: “Combining Medication with Psychotherapy to Improve Compliance.” Santa Clara Valley
Mental Health Center, August 2003.
Invited Lecture: “A Meta-analysis of Antipsychotic Medications – Are the Second-generation Agents Better
than the First-generation Agents?” 1) Westchester Medical Center and 2) Rockland State Hospital,
August, 2003.
56
56
Lecture Tour: “First vs Second Generation Antipsychotics: Efficacy and Use of Polypharmacy Strategies.”
Asahiyama, Tottari, Osaka, Fukuoka and Saga, Japan, September, 2003.
Grand Rounds: The New Atypical Antipsychotics, Phoenix, October 2003,
• Good Samaritan Hospital
• Phoenix V.A. Hospital
CME: “Management of Treatment Refractory Schizophrenia,” UC Davis and Sacramento County, September
2003.
Grand Rounds: “Use of Atypicals in Special Populations,” at the Medical College of Georgia and at Augusta
VA Psychiatric Hospital, Augusta, GA, October, 2003.
Grand Rounds: “New Treatments for Psychosis,” at the Mayo Clinic, at the University of Minnesota Medical
School and at Minneapolis VA Medical Center, October, 2003.
Grand Rounds: “New Treatment for Treatment Resistant Schizophrenia,” Kirby Forensic Psychiatric Center,
New York City, November, 2003.
At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 2003:
• Study Group Co-Chair, “New Comparative Studies of Antipsychotics: Evidence from Controlled Trials
versus Clinical Practice” and presentation on Efficacy of Antipsychotics.
• Chair, Third Annual Session on “Teaching of Neuropsychopharmacology.”
• Poster: “Maintenance Therapy with Haloperidol Decanoate or Quetiapine.”
• Poster: “Issues Which May Determine Outcome of Antipsychotic Trials: Populations, Sponsorship,
Design, etc.”
• Poster: “Update on Psychopharmacology Curriculums: Is There Any Relationship of Teaching to Clinical
Practice?”
Grand Rounds: “A Meta-analyses of the Efficacy of Antipsychotics,” Harvard-Longwood Grand Rounds
Services and Caritas St. Elizabeth’s Hospital Series, Boston, January 2004.
Invited Lectures, New Data, Treatments and Controversies about Schizophrenia and Psychosis, India,
February, 2004.
• Goa Psychiatric Society
• Bombay “
• Calcutta “
• Gowati “
• Dehli “
• Kochin-Kerola “
Grand Rounds: “Combining Psychotherapy with Medication: Is It Helpful?” Kern Medical Center, Bakersfield,
CA, April, 2004.
Invited Lecture: “Antipsychotics for Bipolar Disorder: Monotherapy an Adjunct?” Central California Psychiatric
Society, Bakersfield, April, 2004.
At the Annual Meeting of the American Psychiatric Association, New York, May, 2004:
• Issue Workshop participant: “Evidence-based treatment for schizophrenia in a correctional setting.”
• Symposium discussant: “Personality disorders in the workplace.”
• Master Educator Clinical Consultation: “Combining and integrating medication and psychotherapy for
schizophrenia and other Axis I disorders.”
57
57
Grand Rounds: “Practical Management of Psychoses at South Nevada Adult Mental Health Center,” Las
Vegas, May, 2004.
At the Annual Meeting of NCDEU, Phoenix, June 2004
• Poster: “Maintenance Therapy with Haloperidol Decanoate and Quetiapine: A Controlled Random
Assignment Study.”
Lecture: “Families in the Treatment of Personality Disorders and Issues of Compliance.” As part of the
symposium Personality Disorders: Research & Treatment – An Update. Stanford University Medical
Center, June, 2004.
Lecture: “Terrorism, Changing Family Roles and Functions – and Women’s Wellness: Part II.” Women’s
Wellness Rounds, Stanford University School of Medicine, June, 2004.
Grand Rounds: “What Does Psychotherapy Add to Medication Alone for Axis I Disorders.” Dept Psychiatry &
Behavioral Sciences, Stanford Univ School of Medicine, Sept, 2004
Grand Rounds: “Combining Medications and Psychotherapy.” Dept of Psychiatry, University of Iowa School of
Medicine, September, 2004.
Grand Rounds: “Antipsychotic Use in Special Populations.” Dept of Psychiatry, UCSF University Medical
Center, Fresno, CA, October, 2004.
Lecture: “New Treatments for Schizophrenia.” Univ of Oklahoma Health Sciences Center, Oklahoma City,
October, 2004
Grand Rounds: “New Treatments for Psychosis.” Fulton State Hospital, Fulton, MO, Oct, 2004.
Grand Rounds: “New Treatments for Psychosis.” Dept of Psychiatry, University of Missouri, Columbia, MO,
Oct, 2004.
Grand Rounds: “New Treatments for Schizophrenia.” Dept of Psychiatry, Univ of Kansas School of Medicine,
Wichita, KA, October, 2004.
Lecture: “New Treatments of Schizophrenia.” North West Missouri State Hospital, Kansas City, KA, October,
2004.
CME Program: “A Workshop: Interpreting Mental Health Scales and Their Practical Application to Your
Practice.” 2004 US Psychiatric and Mental Health Congress, October, 2004.
• Chair
• Lecture: “Assessment Scales: How Are They Useful?”
At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December, 2004:
• Poster: “New Developments in Teaching of Psychopharmacology,” with Sid Zisook.
• Poster: “Second Generation Atypicals vs. First Generation Decanoate,” with Stephen Marder.
• Poster: “Analysis of Industry vs Investigator Initiated Trials,” with John Davis.
• Chair: Fourth Annual ACNP “Teaching of Psychopharmacology” session.
Lecture: “Combination Drug Strategies in Schizophrenia.” As part of the symposium Stanford
Psychopharmacology: Course and Clinical Update. Stanford University Medical Center, March, 2005.
Lecture: “Metabolic Issues of Atypical Antipsychotics.” Dominican Santa Cruz Hospital, March, 2005.
Consultant: “Antipsychotic Drugs.” Smith Barney Citigroup 2005 Healthcare Conference, Washington, D.C.,
March, 2005 (with John Kane, M.D. and Les Citrone, M.D.).
58
58
At the 2005 Annual Meeting of the American Psychiatric Association, Atlanta, GA, May, 2005.
• Debate, Resolved: Seccond Generation Antipsychotics are Uniformly Superior in Safety and Efficacy to
First Generation Antipsychotics.
Moderator: Richard E. D’Alli, MD
Affirmative: Ira D Glick, MD, John M Davis, MD
Negative: Rajiv Tandon, MD, William T Carpenter, Jr., MD
• Chair, Symposium, “Use of Concomitant or Adjunctive Medications in Schizophrenia,”
• Paper presentation, “Efficacy of Concomitant Medications for Stabilized Patients with
Schizophrenia,” (with J Davis).
•Paper presentation, “The Challenge of Teaching Psychopharmacology in the New Millennium:
The Role of Curriculum” (with S Zisook) as part of Symposium “Teaching Psychopharmacology in
the 21st Century.”
• Chair, Symposium, “Inpatient Psychiatry: Crisis and Response.”
• Paper presentation, ”Inpatient Psychiatry at the Turn of the Century” (with G Carter & R Tandon).
ASCP Corner: “Challenges and Opportunities in Teaching Psychopharmacology During Residency Training.”
Zisook S, Glick I, Goldberg DA.” J Clin Psychiatry 66:7, July 2005
Lecture: “Careers in Geriatric Psychopharmacology:” Collaboration with Big Pharma,” at the Eleventh Annual
Summer Research Institute in Geriatric Psychiatry, Stanford University, July 2005
Grand Rounds: “Update on Schizophrenia and Bipolar Disorder.” Sacred Heart Hospital, Spokane, WA,
October, 2005.
Grand Rounds: “Update on Schizophrenia and Bipolar Disorder.” American Lake VA, Tacoma, WA, October,
2005.
CME Lecture: “Overcoming the Issues of Noncompliance in Schizophrenia,” at the 2005 U.S. Psychiatric &
Mental Health Congress, Las Vegas, October, 2005.
Grand Rounds: “New Atypicals.” Shasta Community Mental Health, Redding, October 2005.
At the Annual Meeting of the American College of Neuropsychopharmacology, Hawaii, December, 2005:
• Chair: Fifth Annual “Teaching Neuropsycopharmacology” session: The Neglected Constituencies: Can
Teaching About Psychopharmacology Change Attitudes and Practices?
• Paper: “The Challenge of Teaching at the Academic-Industry Interface” (with Terence Ketter).
Invited CME Lecture: “New Treatments for Schizophrenia,” Psychopharmacology Update for Visiting Clinical
Research Psychiatrists from Spain, Stanford University School of Medicine, January, 2006.
Invited Lecture: “Results From the CATIE Study as a part of the Stanford Psychopharmacology Course and
Clinical Update. Stanford University Medical Center, March 2006.
Grand Rounds: “New Treatments for Schizophrenia.” Bismarck Community Mental Health Center, Bismarck,
North Dakota, April 2006.
Invited Lectures: The CATIE Study: What Does It Mean In the Context of the Field, Japan, May, 2006.
• Tokyo • Akita
• Fukuoa • Nagoya
• Toshugi • Hiroshima
• Saitama
At the Annual Meeting of the American Psychiatric Association, Toronto, May, 2006.
• Poster: “Clinical and Metabolic Impact of Switching Antipsychotic Therapy” (with J Kim and G Reaven)
59
59
Grand Rounds: “The CATIE Study: New Results.” Department of Psychiatry and Behavioral Sciences,
Stanford, CA, June, 2006,
At the Annual NCDEU Meeting, Boca Raton, Florida, June, 2006:
• Poster: “A New Psychopharmacology Curriculum for the Teaching of Psychopharmacology.”
At the Biannual Meeting of the CINP (Collegium Internationale NeuroPsychopharmacologium, Chicago, July
2006
• Presenter: “The CATIE Study in Context,” Debate, (Chair, H. Meltzer)
• CME Update: “Meeting the Challenges of Obtaining Optional Outcomes in Schizophrenia; Improving
Function Over the Long Run,” (with Meltzer H, Altamura C and Lindenmeyer JP)
CME Update: “The CATIE Study.” Fresno Community Mental Health Center, August 2006.
Neuropsychiatry Collaborative Grand Rounds: “New Advances in the Neuroscience and Treatment of
Schizophrenia: The CATIE Study.” Stanford University School of Medicine, September, 2006
At the APA 58th institute on Psychiatric Services, New York, October, 2006:
• Workshop: “Concomitant Medication in Schizophrenia: What We Know, Don’t Know, and Ignore” (with
Miranda Chakos and Jay Patel)
• Poster: “Metabolic Impact and Psychiatric Outcome of Switching Antipsychotic Therapy to
Aripiprazole After Weight Gain” (with J Kim and G Reaven).
Grand Rounds: “Combining Medication with Psychotherapeutic Intervention,” Downstate Medical Center,
SUNY, Brooklyn, October 2006.
Grand Rounds: “The CATIE Study: Clinical Implications,” at the Porterville Developmental Center, and at the
Tulare County Mental Health Clinic, Fresno, CA 2006.
Invited Lectures: 1) The New Model of Acute Inpatient Treatment of Schizophrenia, and 2) Improving the
Efficacy of Outpatient Treatment with Intramuscular Antipsychotic Treatment, China, November, 2006.
• Beijing
• Shanghei
• Sunya
At the Annual Meeting of the ACNP, Hollywood, FL, December 2006
• Posters:
• Onset of response with oral paliperidone extended-release tablets in patients with acute schizophrenia
• Metabolic impact and psychiatric outcome of switching antipsychotic therapy to aripiprazole after
weight gain
• The challenge of teaching psychopharmacology in the new millennium: the role of curricula
• Chair, ACNP Teaching Neuropsychopharmacology Plenary (with S Zisook)
• Co-chair, Issues in Ethics Plenary session (with D Braff)
• Presentation: Working w/Industry Collaboratively and Ethically
Lecture: Schizophrenia: Current Treatment. Rockland Psychiatric Center, White Plains, NY, December 2006.
Lecture: “New Models for Inpatient Psychiatry and Partial Hospitalization Programs.” Outpatient Psychiatric
Services, Fairmont Hospital Campus, San Leandro, CA January, 2007.
Lecture: “CATIE Investigator Education Series.” Los Angeles, Seattle and San Francisco, Winter, 2007
Grand Rounds: “The CATIE Trial in Context.” University of Utah Neuropsychiatric Institute (UNI), Salt Lake
City, UT, February 2007.
60
60
Lecture: “Update on Treatment of Schizophrenia: Data from CATIE & Cutlass Trial.” 11th Annual
Psychopharmacology Course & Clinical Update 2007. Stanford University School of Medicine, Department of
Psychiatry & Behavioral Sciences, Stanford, CA, March, 2007.
Lecturer: “CATIE Investigators’ Educational Series,” Los Angeles, San Francisco, Seattle, March, 2007.
Invited Plenary Lecture: “New Treatment Options for Schizophrenia,” at the Global Meeting Training-the-
Trainees (Paleperidone ER). Johnson & Johnson Pharmaceutical, Barcelona, Spain, May 2007.
At the Annual Meeting of the Society of Biological Psychiatry, San Diego, May 2007
• Presenter and Moderator: Workshop on “Concomitant Medication in Schizophrenia” (with Miranda Chakos)
• Poster: “Determination of onset of response to treatment with paliperidone extended-release in patients with
acute schizophrenia.”
At the Annual Meeting of the American Psychiatric Association, San Diego, May 2007
• Paper: “An Overview of the Field of Sports Psychiatry,” as part of a symposium, “How to Practice Sports
Psychiatry: A Demonstration.”
Grand Rounds: “Understanding and Treating Schizophrenia: Final Results from the CATIE Study.” Stanford
University School of Medicine, Stanford, May, 2007.
Grand Rounds: “The CATIE Study and New Treatments for Schizophrenia,” at the MetroHealth Hospital and at
the Department of Psychiatry, Case Western State University, Cleveland, June 2007
Invited Lecture. “The New Model of Inpatient Psychiatry: Intensive Care and Beyond,” Contra Costa Medical
Center, Martinez, CA, November, 2007.
At the Annual Meeting of the ACNP, Boca Raton, Florida, December, 2007
• Co-chair, ACNP Teaching Neuropsychopharmacology – An Epiphany for Psychopharmacology
Education for Residents and Practitioners: A Demonstration (with Constantine Lyketsos); •
Presentation: “Using a Model Curriculum for the Standard Lecture Format: Having the Content and
Lighting the Fire,” (with Sid Zisook).
• Posters:
• Industry sponsorship and outcome at antipsychotic trials (with John Davis)
• Do concomitant medications improve outcome of antipsychotic monotherapy for stabilized patients
with non-acute schizophrenia? (with John Davis)
• Patterns of response with paliperidone ER and placebo in patients with schizophrenia (with C Bossie,
C Canuso, Y Zhu and L Alphhs)
Grand Rounds: “Proven Efficacy in Schizophrenia: Highlights.” Kaweah Delta Mental Health Hospital, Visalia,
CA, January, 2008
Resident Forum: “Schizophrenia Update,” UCSF Fresno Center, Fresno, CA, January, 2008
Grand Rounds: “Current Treatment of Schizophrenia after CATIE and CUtLASS.” Department of Psychiatry,
New York University School of Medicine, NY, March 2008.
At the Annual Meeting of the American Psychiatric Association, Washington, DC, May 2008.
•Posters:
• “Aripiprzole in the Treatment of Schizoaffective Disorder Patients: A Pooled Analysis from Two
Randomized, Double-blind, Placebo-controlled Trials,” first author.
• “Patterns of Response with Paliperidone ER and Placebo in Patients with Schizophrenia,” first author.
61
61
At the NCDEU Annual Meeting, Phoenix, AZ, May, 2008
Poster: The efficacy of aripiprazole on the five dimensions of schizophrenia derived by factor analysis:
Pooled data from five short-term studies (with Philip Janicak et al)
Workshop: Psychopharmacology Education for Residents, Clinicians, and Industry Personnel: A
Demonstration. Chair
Presentation: Teaching Psychopharmacology: A Complete Curriculum
At the XXVI CINP Congress – 50th Anniversary of the CINP, Munich, Germany, July, 2008
Paper: “What have we learned from the present generation of multi-target agents for schizophrenia? How
does pharmacology link to clinical actions?” (with Davis J and Leucht S)
Grand Rounds: “Combining Medication and Psychopharmacology for Axis I Disorders.” Northshore University
Hospital, Glen Cove, New York, Sept 2008
At the Annual Meeting of the Association of Academic Psychiatry, Santa Fe, Sept, 2008
• Poster: “Going globally with a psychopharmacology curriculum for residents, medical students and
clinicians.” (with Zisook, S)
• Special Session: “Problems & strategies of teaching cutting-edge clinical psychopharmacology for
residents and medical students.”
• Workshop: “A group networking exercise to increase collaborative scholarship in writing.” (with Hilty, D)
At the Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, AZ, Dec. 2008
• Co-Chair, Teaching Neuropsychopharmacology Session. “Teaching Psychopharmacology: Successes and
Failures in Determining Whether Anyone Learned Anything (or Did the Message Get Across?”) 8th Annual
ACNP Educational Plenary Session:
• Presentation: “Evaluating Med Student and Residency Competency in Psychopharmacology.”
• Study Group: Long-Term, Large-Scale Clinical Trials of Psychiatric Medications and Treatment Strategies
Chair: Ira Glick with D Klein, H Kraemer, T Insel, M Trivedi, J Coyne, J Csernansky
• Poster: “Aripiprazole in Schizophrenia Patients wih Comorbid Obsessive-Compulsive Symptoms.”
• Poster: Exploration of Placebo Response Found in Recently Conducted vs. Earlier Trials of Patients with
Schizophrenia,” with Larry Alphs, Ibrahim Turkoz, Carla Canuso, Cynthia Bossie.”
Grand Rounds: “Barriers to Academic-Industry Education and Research Collaboration.” Department of
Psychiatry, Stanford University School of Medicine, Stanford, CA, Feb 2009
Panel Participant: “Psychiatry and Pharma: Where Do We Draw The Line?” Northern California Psychiatric
Society, 50th Annual Meeting, Monterey, CA, March, 2009, with Stotland N and Reus V.
At the Annual Meeting of the American Psychiatric Association,” San Francisco, May, 2009.
• “A New Model for Acute Psychiatric Hospitalization, in the symposia, Advances in Hospital Psychiatry, with
R Tandon.
• “Family Intervention to Improve Efficacy and Effectiveness of Medication for Schizophrenia,” as part of
symposia on Optimizing Treatment Outcome in Axis I Disorders: Augmentation with Family Interventions.
Grand Rounds: Berkshire Medical Center, Pittsfield, MA, July, 2009
• Staying Current in Psychopharmacology
• Current Treatments of Schizophrenia
Medical Expert Witness: at the Trial Academy, International Association of Defense Counsels, Stanford, July
2009.
New York City, Payne Whitney Clinic of New York Hospital and at the Westchester Division of New York Hospital. New York November, 2012.
62
62
Grand Rounds: Mid-term and Long-Term Efficacy and Effectiveness of Antipsychotic medications for Schizophrenia: A Data-Driven Personalized Clinical Approach, At the Weill Cornell Medical College, New York City, Payne Whitney Clinic of New York Hospital and at the Westchester Division of New York Hospital. New York November, 2012. Grand Rounds: Mid-term and Long-Term Efficacy and Effectiveness of Antipsychotic medications for Schizophrenia: A Data-Driven Personalized Clinical Approach, At the Weill Cornell Medical College, New York City, Payne Whitney Clinic of New York Hospital and at the Westchester Division of New York Hospital. Beth Israel Medical Center, New York, December 2012.
Invited Lecture.
At the Department of Psychiatry, Polyclinic Hospital School of Medicine, University of Milan, October, 2009.
• Long-term Treatment of Schizophrenia
• The Art of Psychopharmacology
Invited Participant
• “The High Prevalence of Poor Medication Adherence in Schizophrenia,” as part of a Forum, Value of Long-
acting Therapies (LATS), supported in part by Janssen, Las Vegas, October, 2009
At the 3rd International Forum on Innovation in Psychiatry, Milan, Italy, November, 2009
• Long-term Antipsychotic Treatment: Modality, Problems and Comparisons
At the 3rd Annual International Brain Conference, Lake Buena Vista, FL, December, 2009
• An Analysis of Recent Research on Schizophrenia: Long-term Safety and Efficacy of Antipsychotics
At the 48th ACNP Annual Meeting, Hollywood, FL, December, 2009
• Poster: “A Model Curriculum for Teaching Medical Students Psychopharmacology”
• Poster: “Family Presence and Support is Correlated with Outcome for Patients with Chronic Schizophrenia
• Chair, Teaching Neuropsychopharmacology, 9th Annual ACNP Educational Plenary Sessison, “The
Impossible Dream:” Keeping Up with Clinical Neuroscience & Psychopharmacology, Circa 2010
• Lecture: “ A Radical Proposal for Staying Current”
Invited Lecture as part of the Parent-Education Series at Marin Academy, San Rafael, CA, Feb, 2010
• “Family Function and the Teen Years: Surviving, Let-alone Thriving.”
Invited Lecture at the 14th Congress of the Italian Society of Psychopathology (SOPSI), Rome, Feb, 2010
• “Evaluation of the Efficacy of Atypical Antipsychotics on Major Psychosis with Long-term Treatment.”
Invited Lecture at the Northern California Psychiatric Society, 2010, Annual Meeting, Monterey, March, 2010
• “Cutting Edge Treatment for Schizophrenia: New Data and New Treatments for the Clinician”
At the 2010 APA Annual Meeting, New Orleans, May, 2010
• Course organizer and lecturer for Psychopharmacology Master Course, Essential Psychopharmacology:
“Staying on the Cutting Edge of Advances in Clinical Psychopharmacology,”
Lecture, “Pharmacotherapy of Schizophrenia: Clinical Implications of New Research”
• ASCP Psychopharmacology Course, Translating the Psychopharmacology Evidence Base into Practice:
A sampler from ASCP,
Lecture, “Combining Medication and Psychotherapeutic Intervention for Axis I disorders”
At the New Clinical Drug Evaluation Unit Meeting (NCDEU) Boca Raton, FL, June 2010,
Panel• Combining Medication with Psychosocial Intervention to Improve Outcome of Axis I Disorders, Co-
Chair.
63
63
Lecture, “Combining Medication with Psychosocial Intervention to Improve Outcome of Schizophrenia,
(with Marder S)”
At the 2010 ASCP Clinical Update, New York, October, 2010
• Lecture: “Update on the Treatment of Schizophrenia”
At the 2010 Meeting of the German Association for Psychiatry and Psychotherapy, Berlin, Germany, November
2010
• Lecture: “An Overview of Sport Psychiatry: A New Frontier in a Changing World”
At the 2010 Meeting of the American College of Neuropsychopharmacology, Miami, December 2010
• Chair, Teaching Psychopharmacology, 10th Annual ACNP Educational Plenary Session: New
Development in Psychopharmacology
• Paper presentation, The American Society of Clinical Psychopharmacology
Curriculums for 1) Residents, 2) Medical Students, and 3) Primary Care Physicians.
• Posters:
• Long-Term Efficacy & Effectiveness of Antipsychotic Medication for Schizophrenia, A Data-
Driven Personalized, Clinical Approach. (with John Davis)
• New Model Curriculums for Teaching Psychopharmacology to Residents, Medical Students,
and Primary Care Prescribers. (with Bruce Lydiard)
Lecture: Psychopharmacologic Treatments for Schizophrenia, 16th Annual Psychopharmacology
Update, Nevada Psychiatric Association, Las Vegas, February 2011.
At the 2011 APA Annual Meeting, Honolulu, May 2011:
• Lecture: Strategies of Treatment for Treatment Resistant Schizophrenia as part of the Masters Course,
entitled “Essential Psychopharmacology”
• Lecture: Sport Psychiatry and Traumatic Brain Injury: New Frontiers in a Challenging World as
part of a Symposium, Traumatic Brain Injury in the Athlete: Psychiatric Implications (with Reardon, D,
Morse, E, Newmark, T)
• Lecture: The Development of Psychopharmacology for Psychiatric Residents as part of Symposium
The Importance of Biological Psychiatry and Clinical Psychopharmacology in Teaching Psychiatric
Residents (with Peselow, E)
• Co-Chair and Lecture 1. Models of Family and Couples Therapy and 2. Evidence Basis for
Family Intervention in Axis I Disorders as part of Symposium Integrating Couples and Family
Treatment into Patient Care.
At the 51st Annual NCDEU Meeting, Boca Raton, FL, June 2011:
• Research Report: “Long-term Efficacy and Effectiveness of Antipsychotic Medication for Schizophrenia,
a Data-driven Personalized, Clinical Approach” (with Davis J. Marder, S et al)
• Poster: New Model Psychopharmacology Curriculum for Residents, Medical Students and Primary Care
Physicians
Invited Lecture. “The New Psychiatry: Past, Present, (& Maybe) The Future of Treatment”, Rhoda Goldman
Institute, San Francisco, July, 2011.
At the 2011 American Physician Institute CME Course, San Diego, October, 2011, lectures:
64
64
Current Update on Treatment of Schizophrenia
New Medications and New Strategies of Treatment for Schizophrenia over the Long-Run
Invited Lecture, New Data and New Strategies of Treatment for Schizophrenia, Psychiatric Grand Rounds, San
Quentin Prison, CA, October 2011
Invited Lecture, New Neuroscience and Genetic Advances as They Affect Psychology and Psychiatry, at the
Department of Psychology, Lehigh University, Bethlehem, PA, November 2011.
Chair: All-day Update on the Current Understanding and Treatment of Schizophrenia, at the 17th Annual
Psychopharmacology Update, Nevada Psychiatric Association, February 2012.
Lecture, Long-Term Management and Treatment of Chronic Schizophrenia
Lecture: Update on the Treatment of Schizophrenia, Fremont Hospital, Fremont, CA, April, 2012.
At the 2012 American Psychiatric Association Annual Meeting, Philadelphia, May 2012:
Lecture: Psychological Impact of Injury in the Athlete, as part of a symposium, “Rebound and Recovery in the Athlete,” with Tom Newmark
Discussant: “Here One Day - A Film About Bipolar Disorder and Suicide”
Lecture: “New Treatment for Schizophrenia”, as part of Masters Course, Essential Psychopharmacology
Co-chair and Symposium Discussant: Improving Quality of Care for Patients with Psychiatric Illness: Combining and Integrating Psychopharmacological, Individual, and Family Therapy
At the 2012 NCDEU Annual Meeting, Phoenix, June, 2012
Special Educational Session, Improving the Teaching-Learning Process in Psychopharmacology: A
Demonstration of New Teaching Formats From the ASCP Psychopharmacology Curriculum
o Lecture: The New Seventh Edition of the ASCP Model Psychopharmacology Curriculum
Posters
o Going Electronic: Moving Data and Discovery to Pharmacology Teachers
o Efficacy and Safety/Tolerability of 2 Approaches for Switching to Iloperidone in Patients With
Schizophrenia, With Weiden P, Alva G, et al.
Grand Rounds, Update on Schizophrenia, John George Pavilion of the Alameda County Medical Center, Fremont, CA, July 2012.
Data Monitoring Committee for VA Cooperative Study 576; VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D), 2012-2014
Grand Rounds, New Data and New Strategies for Cutting-Edge Treatments of Schizophrenia, Department of Psychiatry, Weill Cornell Medical College, Payne Whitney Clinic, New York City and at Westchester Division, White Plains, New York, November, 2012.
Grand Rounds, New Data and New Strategies for Cutting-Edge Treatments of Schizophrenia, Department of Psychiatry, Beth Israel Medical Center, New York, December, 2012. At the 2013 American Psychiatric Association, Annual Meeting, San Francisco, May, 2013
Invited Presidential Symposia: Cutting – Edge Treatment of Schizophrenia over the Life Cycle: New Data and New Strategies, Lecture: Mid-Term and Long-Term Treatments of Schizophrenia
65
65
Discussant of Documentary Film, “Unlisted: A Story of Schizophrenia.” At the 2013 NCDEU Annual Meeting, Hollywood, Florida, May, 2013
Lecture: Efficacy of Clozapine and Reasons for Under-utilization, as part of a workshop, The Under-utilization of Clozapine: Reasons and Solutions (Chair JP. Lindenmayer)
Debate Participant: Hybrid Trial Networks. Leveraging Academic Focus to Assess Unproved Mechanism on Drugs in Psychiatric Disorders, as part of a workshop: Neuroscience vs Serendipity in Psychiatric Drug Development: A Debate
Organizer and Lecturer of Workshop, Impediments/Barriers to Effective Teaching – Learning of Psychopharmacology.
o Lecture: The Seven Sins of Psychopharmacology Teaching (Co-author Salzman, C)
Posters: 1)Improving Psychopharmacology Education and Practice: The Quandary of Getting Data and Information to the Teachers and 2) Web-based Curriculums for Teaching Psychopharmacology
Grand Rounds: Mid-Term and Long-Term Treatments of Schizophrenia. University of California, San Diego, San Diego, CA, June 2013. Grand Rounds: Cutting Edge Treatment of Schizophrenia New Research and New Strategies, Albert Einstein College of Medicine and Montefiore Hospital, Bronx, New York, October 2013. Grand Rounds: Mid-Term and Long-Term Treatments of Schizophrenia, Dept of Psychiatry, University of Massachusetts, Wooster, Mass, February 2014. Invited Lecture: The New Neuroscience – and Psychology, Psychiatry and Medicine. Clarke Forum for Contemporary Issues, Dickinson College, February 2014. Invited Lecture: Long-Term Treatment of Schizophrenia, at the 2014 Annual Meeting of the Northern California Psychiatric Society, Monterey, Ca, March 2014. Invited Lecture: New Neuroscience: Psychology, Psychiatry and Medicine. Department of Psychology, Wesleyan
University, Middletown, CT, May 2014.
Invited Lecture: A Focus on Treatment of Schizophrenia: New Data and New Strategies, at the Dept of Psychiatry,
University of Minnesota, Minneapolis, Minnesota, May, 2014.
Grand Rounds: Advances in Drug Treatment of Schizophrenia, Dept of Psychiatry, Alameda Health System, San
Leandro, Ca, June, 2014
At the 2014 Annual American Society of Clinical Psychopharmacology, Hollywood, Fla, June, 2014 (repeated at
the 2014 Annual Meeting of the Am College of Neuropsychopharmacology, , Phoenix, Az):
Poster: Improving Psychopharmacology Education, with Balon, R and Zisook, S
Poster: Web-based Curriculums for Teaching Psychopharmacology, with the A S C P Curriculum
Committee
.Grand Rounds: New Strategies and New Treatments for Schizophrenia, Dept of Psychiatry, Tufts University
School of Medicine, Boston, September, 2014.
66
66
Grand Rounds: Diagnosis and Treatment in 21st Century Psychiatry, Dominican Hospital, Santa Cruz, Ca, Jan,
2015.
Invited Lecture: Combining Medication with Psychotherapeutic Intervention for Psychiatric Disorders, at the
Northern California Psychiatric Society Continuing Education Meeting, San Francisco, Feb, 2015 and at
the Clinical Psychology Trainees Conference of Alameda Health System, Oakland, Ca,, Feb, 2015 .
Middle East Lecture Tour: Grand Rounds, Update on Current Treatment of Schizophrenia, at Dept of Psychiatry,
Hamad Medical Corp Hospital, Doha, Qatar and at Saif Bin Ghubash Hospital, Dubai, U A E, March, 2015
Grand Rounds: New Strategies and Treatments for Long-term Treatment of Schizophrnia, at the Dept of
Psychiatry, NYU School of Medicine, New York, April, 2015.
At the 2015 American Psychiatric Association, Annual Meeting, Toronto, May, 2015
Lecture “ Can We Treat the Cheat? As part of a symposia, “Cheating, Personality Disorders, and Sport Psychiatry,” with Begel, D.
Grand Rounds : New Treatments and New Strategies for Long-term Treatment of Schizophrenia, Howard
University School of Medicine, Washington D.C., May, 2015
At the Annual Meeting of the American Society of Clinical Psychiatry, Miami, June, 2015:
Workshop: How to Use the Model Psychopharmacology Curriculum in Different Teaching
Settings, with Osser, D
Lecture, The Role of LAIs in the Treatment of Schizophrenia: Outcome Data, with Davis, J.
Ira Glick September 10, 2015